The QualityStocks Daily Stock List
- Argonaut Gold, Inc. (ARNGF)
- TOMI Environmental Solutions, Inc. (TOMZ)
- Cruz Cobalt Corp. (BKTPF)
- Elron Electronic Industries Ltd. (ELRNF)
- Eurosport Active World Corp. (EAWD)
- Greene Concepts, Inc. (INKW)
- Sino United Worldwide Consolidated Ltd. (SUIC)
- Nautilus Minerals, Inc. (NUSMF)
- Medibio Limited (MDBIF)
- Bemax, Inc. (BMXC)
- SETO Holdings, Inc. (SETO)
- The Pulse Beverage Corporation (PLSB)
- Blow & Drive Interlock Corp. (BDIC)
- Yappn Corp. (YPPN)
Argonaut Gold, Inc. (ARNGF)
The Northern Miner, StockScores, StockInvest, Stock Guru, StocksBeat, Mining Stock Valuator, Canadian Mining Journal, Invest Tribune, Wallmine, StockInvest, and TipRanks reported previously on Argonaut Gold, Inc. (ARNGF), and today we report on the Company, here at the QualityStocks Daily Newsletter.
Argonaut Gold, Inc. engages in exploration, mine development, and production activities in North America. The Company primarily explores for gold and silver deposits. Its main assets include the El Castillo mine located in the State of Durango, Mexico; and the San Agustin project positioned in the State of Durango, Mexico. In 2019, Argonaut Gold plans to invest $50 to $60 million in capital expenditures (capex). Argonaut Gold has its head office in Reno, Nevada and the Company lists on the OTC Markets.
Together, the El Castillo mine and the San Agustin project form the El Castillo Complex in Durango, Mexico, and the La Colorada mine in Sonora, Mexico. Furthermore, Argonaut Gold’s advanced exploration projects include the San Antonio project in Baja California Sur, Mexico; the Cerro del Gallo project in Guanajuato, Mexico; and the Magino project in Ontario, Canada. In addition, the Company has several exploration stage projects, all of which are in North America.
In 2019, Argonaut Gold expects to produce more than 200,000 GEOs (gold equivalent ounces) annually from its existing operations. This would reflect greater than 65 percent production growth from 2017 through 2019. This production growth is chiefly driven by the ramp up of the El Castillo Complex with the addition of San Agustin and the extension of mine life at El Castillo subsequent to the San Juan concession purchase from Fresnillo Plc, as well as higher anticipated grades at La Colorada as mining transitions to the El Creston pit.
This month, Argonaut Gold announced its operating and financial results for Q2 ended June 30, 2019. It reported quarterly Production of 40,213 GEO, Cash Flow From Operating Activities Before Changes In Operating Working Capital of $11.3 million, and Net Income of $5.4 million or Earnings Per Share of $0.03.
Argonaut Gold remains on course to attain its 2019 production guidance. Nevertheless, because of the elevated costs experienced during the first half of 2019, mainly because of the shortage of water at the San Agustin mine, its is revising its cost guidance. It anticipates it will produce between 200,000 and 215,000 GEOs during this year at a cash cost of between $800 to $900 per gold ounce sold (previously $775 to $875 per gold ounce sold) and All-In Sustaining Costs (AISC) of between $1,025 and $1,125 per gold ounce sold (previously $975 to $1,075 per gold ounce sold).
Argonaut Gold, Inc. (ARNGF), closed Friday's trading session at $1.98, up 6.9709%, on 23,200 volume with 40 trades. The average volume for the last 3 months is 37,305 and the stock's 52-week low/high is $0.852100014/$2.15000009.
TOMI Environmental Solutions, Inc. (TOMZ)
Infront Analytics, TeleTrader, Morningstar, Simply Wall St, GuruFocus, Wallmine, Stockopedia, InvestorsHub, Capital Cube, Last10k, Wallet Investor, Stockhouse, 4-Traders, GlobeNewswire, Seeking Alpha, and Market Screener reported on TOMI Environmental Solutions, Inc. (TOMZ), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
TOMI Environmental Solutions, Inc. is an international company headquartered in Beverly Hills, California. It specializes in disinfection and decontamination employing its premier Binary Ionization Technology® (BIT™) platform via the manufacturing, licensing, servicing, and selling of its SteraMist® brand of products - a hydrogen peroxide-based mist and fog. The four principal divisions of TOMI include Hospital-Healthcare, Life Sciences, TOMI Service Network (TSN), and Food Safety. The Company lists on the OTC Markets Group’s OTCQB.
The design of TOMI products are to service a wide array of commercial structures. In addition, the Company’s products and services have been used in single-family homes and multi-unit residences. TOMI Environmental Solutions develops training programs and application protocols for its clients. TOMI is a member in good standing with The American Biological Safety Association, The American Association of Tissue Banks, Association for Professionals in Infection Control and Epidemiology, Society for Healthcare Epidemiology of America, and The Restoration Industry Association.
TOMI’s BIT™ solution uses a low percentage Hydrogen Peroxide as its only active ingredient to produce a hydroxyl radical (.OH ion), referred to as ionized Hydrogen Peroxide (iHP™). Represented by the SteraMist® brand of products, iHP™ produces a germ-killing aerosol. This aerosol works like a visual non-caustic gas. SteraMist is an EPA (Environmental Protection Agency) registered sole active ingredient Hydrogen Peroxide based product line.
In 2015, TOMI Environmental Solutions received its first EPA hospital-healthcare general disinfectant label, in what is regarded as a heavily regulated and very competitive industry. In 2016, the Company amended the label to include C.difficle spores and h1n1. In 2017, the EPA approved additional registrations of Salmonella and Norovirus to the TOMI label. Additionally, Binary Ionization Technology (BIT) can be found on EPA Lists K, L, G, and M.
Recently, TOMI Environmental Solutions announced that it manufactured, installed, and validated a SteraMist® iHP™ Plasma Decontamination Chamber, a new Company product offering, at the University of Houston. The University of Houston will use its newly designed iHP Plasma Decontamination Chamber weekly to at the same time disinfect up to 300 rodent cages in three hours. TOMI programmed the system with pre-set programs that will permit versatility in disinfecting other lab equipment as required.
TOMI Environmental Solutions will hold its Q2 2019 financial results conference call on Monday, August 26th at 1:30 p.m. PT, 4:30 p.m. ET.
TOMI Environmental Solutions, Inc. (TOMZ), closed Friday's trading session at $0.081, off by 7.9545%, on 16,218 volume with 2 trades. The average volume for the last 3 months is 8,700 and the stock's 52-week low/high is $0.059999998/$0.180000007.
Cruz Cobalt Corp. (BKTPF)
Geology for Investors, Street Insider, Invest Tribune, Investor Intel, Micro Small Cap, Stocksbeat, Energy and Capital, Investing News, Junior Mining Network, Stockwatch, and 4-Traders reported beforehand on Cruz Cobalt Corp. (BKTPF), and today we report on the Company, here at the QualityStocks Daily Newsletter.
Cruz Cobalt Corp. engages in the acquisition, exploration, and evaluation of mineral properties in the United States and Canada. An exploration stage enterprise, it explores for cobalt and lithium properties. The Company formerly went by the name Cruz Capital Corp. It changed its corporate name to Cruz Cobalt Corp. in February 2017. Cruz Cobalt is based in Vancouver, British Columbia (BC) and lists on the OTC Markets.
Cruz Cobalt is the leading cobalt project generator and developer in North America. The Company focuses on acquiring and developing high-grade cobalt projects in politically stable, environmentally responsible and ethical mining jurisdictions.
Cruz Cobalt’s United States projects include the 1,339 acre Chicken Hawk prospect in Montana and the 80 acre Idaho Star prospect. The Company’s BC prospects include the 15,219 acre War Eagle cobalt prospect and the 11,821 acre Purcell prospect.
Cruz Cobalt's five separate Ontario cobalt prospects are all in the vicinity of the town of Cobalt. This makes Cruz Cobalt one of the largest landholders in this developing cobalt district. The Company's Ontario projects include the 1,265 acre Coleman cobalt prospect, the 900 acre Johnson cobalt prospect, the 4,980 acre Hector cobalt prospect, the 1,580 acre Bucke cobalt prospect, and the 10,556 Lorraine cobalt prospect.
Cruz Cobalt hired experienced geologists to begin operations on its Ontario, BC, Idaho, and Montana projects. The Company has completed an airborne survey over its Ontario cobalt prospects that identified 6 primary cobalt targets. Airborne data gathered on its 2 BC Cobalt properties has shown strong magnetic features within the cobalt prospects. Furthermore, Cruz has commenced work programs on its 100-percent-owned Idaho Star cobalt prospect in Idaho, and its 100-percent-owned Chicken Hawk Cobalt Prospect in Montana.
In December of 2018, Cruz Cobalt announced it completed its diamond drilling program on the Hector Cobalt Property situated near the town of Cobalt, Ontario. The initial diamond drilling program comprised 10 holes and 843 total meters.
Cruz Cobalt Corp. (BKTPF), closed Friday's trading session at $0.0241, even for the day. The average volume for the last 3 months is 45,414 and the stock's 52-week low/high is $0.0152/$0.094999998.
Elron Electronic Industries Ltd. (ELRNF)
Zacks, Market Screener, BioSpace, Morningstar, Investing.com, Street Insider, Capital Cube, Simply Wall St, PR Newswire, Seeking Alpha, GuruFocus, and 4-Traders reported previously on Elron Electronic Industries Ltd. (ELRNF), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.
Elron Electronic Industries Ltd.’s dedication is to its vision of identifying transformative technologies, nurturing gifted entrepreneurs, and building companies into technology leaders. The Company works to build value in venture capital investments. Elron’s field of focus in the last 10 years is medical devices. It is developing the Cyber/IT filed for the next decade. It has a portfolio of companies in which it invested $185 Million. Elron Electronic Industries has its corporate headquarters in Tel Aviv, Israel.
Group companies benefit from Elron’s combined technological, strategic, entrepreneurial and business expertise, extensive networks, and wide attention span. Regarding Medical Devices, Elron invests in treatment-changing, rather than treatment-enhancing, medical device companies. It looks for companies with billion-dollar market potential. It typically invests in the idea/R&D stage.
Concerning Cyber, it invests in first-rate ideas and technologies with the potential to transform or create new markets, and also help make the world a more secure place to live in. It looks for investment opportunities from seed to growth stages.
In addition, Elron Electronic Industries has its RDC Strategic Joint Venture (JV). In 1993, RDC was founded by Elron and Rafael, a worldwide leader of defense technologies and of Israel’s largest defense companies. RDC combines Rafael’s scale and technological edge with Elron’s wide-ranging expertise in assisting start-ups develop into top technology enterprises.
RDC has exclusive rights to commercialize Rafael’s defense technologies in civilian markets. Via RDC, Elron initiates and develops new companies, as well as provides essential support from start to exit.
Elron Electronic Industries’ portfolio includes BrainsGate, Pocared Diagnostics, CartiHeal, Coramaze Technologies, Nitinotes, Notal Vision, and Sixgill. Its portfolio additionally includes Alcide, Cloudyn, SecuredTouch, IRONSCALES, Cynerio, Kindite, 3DV Systems, Teledata Networks, SECDO, Aqwise, OzCode, and Sayata Labs, among many others.
BrainsGate focuses on electrical stimulation-based treatment for ischemic stroke. CartiHeal focuses on an implant for cartilage and bone regeneration in load-bearing joints. Elron’s activity also includes OpenLegacy, which focuses on an automated API integration platform that speeds digital transformation. Open Legacy has a team of 100 employees, in 8 locations internationally. It has more than 20 customers globally, including 1st-tier insurance & banking corps.
Elron Electronic Industries Ltd. (ELRNF), closed Friday's trading session at $1.56, up 15.5556%, on 200 volume with 1 trade. The average volume for the last 3 months is 401 and the stock's 52-week low/high is $1.28999996/$3.71000003.
Eurosport Active World Corp. (EAWD)
Penny Stock Tweets, Street Insider, Market Screener, Wall Street Analyzer, Stockhouse, InvestorsHub, Plunkett Research, Pink Investing, Stockopedia, Investors Hangout, Simply Wall St, Wallet Investor, and Dividend Investor reported beforehand on Eurosport Active World Corp. (EAWD), and we also report on the Company, here at the QualityStocks Daily Newsletter.
EAWC Technologies (EAWC) (also known as Eurosport Active World Corp.) is an engineering services company. It established as an outsourcing services green technology platform that can provide a comprehensive services package to measure the feasibility of the potential technological solutions for a project that looks to achieve the close cycle of waste to energy and water generation through exploiting renewable technologies. EAWC has its corporate office in Miami, Florida. The Company lists on the OTC Markets.
Fundamentally, EAWC works to make available environmentally-friendly and sustainable methods of producing and purifying water, in addition to the generation of energy (Waste-to-Energy). The Company notes that it is well positioned to offer engineering and technical consultancy. This is to design the most accurate renewable technology solutions to the aforementioned problems and to take advantage of this fast-growing industry with many new markets.
EAWC has acquired the relevant licenses that give it the right to sell and produce the associated technologies. This is while ensuring, via its partnership with Swiss Water Tech R&D, the provision of related services. These services include Research & Development (R&D), technical maintenance, education, and training.
EAWC is launching The Blue Aqua Mission™ System. This is a state-of-the-art German engineered Atmosphere Water Generation (AWG) technology. It is completely powered by renewable energy. The system consists of a set of intelligent software solutions for real-time optimization of process performance. It operates via its own inventive self-powered system. The Blue Aqua Mission™ System concentrates on real-time automated optimization of the generation of water, ensuring a stable operation with water generation of up to 10,000 liters of water per day.
EAWC plans to offer its Atmospheric Water Generation technological solutions via lease programs. EAWC Technologies’ commitment is to facilitate the access to water in several countries including South Africa through leasing The Blue Aqua Mission™ Systems.
EAWC announced this past April that an agreement was signed to lease its Atmospheric Water Generation technological solutions through lease programs in South Africa. This agreement to lease The Blue Aqua Mission™ System is with the private South African Company His Will Innovations. It will be the first of many systems planned in the region.
Regarding Research and Development (R&D), EAWC provides engineering studies and analysis to ensure project sustainability, with a specialization in Water & Energy Technologies. Concerning Project Management, the Company assists it customers in finding the best technical solution. If required, EAWC’s team is involved from an early stage of the Project planning until final installation and running operation.
Eurosport Active World Corp. (EAWD), closed Friday's trading session at $0.2999, up 24.9583%, on 35,748 volume with 5 trades. The average volume for the last 3 months is 22,081 and the stock's 52-week low/high is $0.100100003/$3.75.
Greene Concepts, Inc. (INKW)
All Cap Research, Street Insider, OTC Dynamics, The WS News Publisher, Investing.com, Simply Wall St, WeTradeHQ, Otc.watch, Stockwatch, Stockopedia, Investingonline.com, Seeking Alpha, TradingView, otcprwire, Dividend Investor, Morningstar, OTC Markets, Wallet Investor, Stockhouse, Globe Newswire, and InvestorsHub reported earlier on Greene Concepts, Inc. (INKW), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Greene Concepts, Inc. is an emerging leader in the worldwide scientifically formulated beverage industry. Via its recently acquired wholly-owned subsidiary, Mammoth Ventures, Inc., the Company has entered into the specialty beverage and bottling business. Greene Concepts lists on the OTC Markets. The Company is headquartered in Clovis, California.
Greene Concepts entered into a definitive agreement on December 28, 2018 to purchase a bottling and beverage facility. This includes land and equipment. The facility will focus on an array of beverage product lines including, but not limited to, CBD (cannabidiol) infused beverages, spring and artesian water, and enhanced athletic drinks in addition to other product offerings.
Greene Concepts has completed the 100 percent acquisition of Mammoth Ventures, Inc., a holding company. The acquisition includes the 60,000 sq. ft. beverage and bottling facility located just outside of Asheville, North Carolina.
This past June, Greene Concepts announced that it expects a near term operations relaunch with pilot production runs debuting high margin specialty and enhanced beverages targeted for the $93.68 billion worldwide functional drinks market. In preparation for an operations relaunch at the plant, a 30-plus year veteran of the bottling industry was appointed plant manager to supervise all renovations.
This month, Greene Concepts updated shareholders that water purity standards far surpassing industry norms have been implemented at its bottling facility in Marion, North Carolina. The worldwide bottled water industry is forecast to reach $215.12 billion by 2025, according to Grand View Research, Inc. Beverage Marketing corporation projects within the next few years, individual consumers will drink greater than 50 gallons of bottled water annually.
Karen Howard, Chief Executive Officer of Greene Concepts, said, “As our bottling facility approaches relaunch, we are committed to bottling the cleanest water possible, and test to the highest standard for arsenic of no more than .005 mg/liter, the equivalent of 5ppb. The FDA standard is 10ppb.”
Greene Concepts, Inc. (INKW), closed Friday's trading session at $0.0065, off by 0.687548%, on 2,957,099 volume with 19 trades. The average volume for the last 3 months is 2,522,592 and the stock's 52-week low/high is $0.001/$0.054900001.
Sino United Worldwide Consolidated Ltd. (SUIC)
StockAlert, Penny Stock Hub, Real Investment Advice, Investor News, Wallet Investor, MarketBeat, MarketWatch, Simply Wall St, Stockwatch, Global Banking and Finance, Stockopedia, Infront Analytics, Last10k, TMXmoney, GlobeNewswire, Stockhouse, InvestorsHub, and Morningstar reported earlier on Sino United Worldwide Consolidated Ltd. (SUIC), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Sino United Worldwide Consolidated Ltd. is a FinTech (Financial Technology) company. It provides Venture Financing and Blockchain services to five sectors. These include “Logistics & Trade”, “Vehicle & Transportation”, “Finance & Coin”, and “Medical & Healthcare”, and a new addition, “FinTech.” The Company previously went by the name AJ Greentech Holdings Ltd. It changed its name to Sino United Worldwide Consolidated Ltd. in July of 2017. Established in 2009, the Company is based in Flushing, New York. Sino United’s Asian operating center is located in Hong Kong and Singapore.
The Company’s primary business is in Blockchain, in 4 Sectors. These are Blockchain in Logistics and Trade; Blockchain in Vehicle and Transportation; Blockchain in Finance And Coin; and Blockchain in Medical and Healthcare. The addition of the FinTech sector to Sino United’s Blockchain services includes a complete update in which the Company will build up its own internal capabilities through actively starting a Blockchain training program, developing a 3rd generation Smart Contract Blockchain under the Sino United brand, and using these capabilities to provide a comprehensive ICO consultancy.
In December of 2018, Sino United Worldwide Consolidated and USADAE (American Digital Asset Exchange) revealed the Joint Venture (JV) to launch the new FinTech trading platform, embarking on the first worldwide Blockchain conglomerate as a hub for innovative Blockchain technology and unique Blockchain projects. The partnership adjoins the sanctioned practices of regulated and inventive finance and exchanges and the present flourishing digital world enabled by Blockchain, Distributed Ledger and Artificial Intelligence (AI) technologies.
This Sino United-USADAE alliance offers clients security and storage services, and also trade execution for crypto, digital assets. The alliance will merge their strong trading platform technology and premium selection of digital tokens, adopting rigorous assessment utilizing the latest in proof-of-reputation algorithms and other advanced programs.
Last week, Sino United Worldwide Consolidated announced that it and iDrink Technology Co. Ltd., Taiwan signed a Share Exchange Agreement (SEA) to work together on the distribution of iDrink Smart IoT (Internet of Things) Vending Machines in the global market. Upon closing of this SEA, Sino United will acquire a 20 percent stake in iDrink in exchange for delivery, by Sino United to iDrink, of 1,000,000 Sino United Worldwide Consolidated restricted common shares.
Upon closing, Sino United’s plan is to assist iDrink in developing its marketing plans and to implement strategic marketing alternatives internationally. Sino United’s belief is that this interaction is a major milestone, which will provide new growth opportunities for Sino United and iDrink, combining the complementary strengths to become a laterally positioned provider of smart IoT vending solutions.
Sino United Worldwide Consolidated Ltd. (SUIC), closed Friday's trading session at $3.00, up 50.00%, on 201 volume with 3 trades. The average volume for the last 3 months is 1 and the stock's 52-week low/high is $2.00/$6.98999977.
Nautilus Minerals, Inc. (NUSMF)
OTC Markets, PennyStockTweets, Stockhouse, Equities, Marketwired, InvestorsHub, Barchart, Junior Mining Network, The Street, MarketWatch, and YCharts reported previously on Nautilus Minerals, Inc. (NUSMF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Nautilus Minerals, Inc. is the first company to explore the ocean floor for polymetallic Seafloor Massive Sulphide (SMS) deposits. Nautilus is developing a production system utilizing existing technologies adapted from the offshore oil and gas industry, dredging and mining industries to enable the extraction of these high-grade SMS systems on a commercial scale.
Nautilus Minerals has offices in Brisbane, Australia; Canada; and in Kavieng, New Ireland, Papua New Guinea, and Nuku'alofa, Tonga, South Pacific.
A seafloor resource exploration business, Nautilus explores and develops the ocean floor for copper, gold, silver, and zinc SMS deposits. Furthermore, the Company explores for manganese, nickel, copper, and cobalt nodule deposits. Nautilus has its copper-gold project named Solwara 1. It is under development in the territorial waters of Papua New Guinea (PNG).
The Solwara 1 deposit sits on the seafloor at a water depth of about 1600 meters. Solwara 1 contains a copper grade of approximately 7 percent. This compares with land-based copper mines, where the copper grade today averages 0.6 percent.
Gold grades of substantially more than 20 g/tonne have been recorded in some intercepts at Solwara 1. The average grade is roughly 6 g/tonne. Moreover, the Company holds highly prospective exploration acreage in the western Pacific (granted and under application), and in international waters in the Central Pacific.
Nautilus Minerals is currently negotiating the terms of an agreement with arm's length third parties. This would involve the establishment of a new joint venture company (the Vessel JV) to be owned by the third parties and Nautilus’ subsidiary, Nautilus Minerals Niugini Limited (NMN).
The purpose of the Vessel JV would be to fund the acquisition of the Production Support Vessel (PSV) that Nautilus had previously arranged to be obtained through MAC Goliath Pte Ltd (MAC) and the integration expenses of installing the mining equipment on the PSV. The Vessel JV would own and operate the fully integrated PSV.
Recently, Nautilus Minerals announced that it and Deep Sea Mining Finance Ltd. agreed to extend the maturity date of the existing secured loan facility that is currently due on February 8, 2019, for 28 days ending on March 8, 2019.
Nautilus continues to seek short and long term funding solutions. This is while assessing its options, including different restructuring options. Negotiations with various third parties continue.
Nautilus Minerals, Inc. (NUSMF), closed Friday's trading session at $0.0007, up 133.3333%, on 2,060,920 volume with 16 trades. The average volume for the last 3 months is 63,006 and the stock's 52-week low/high is $0.000001999/$0.099799998.
Medibio Limited (MDBIF)
Awesome Penny Stocks, Wallet Investor, The Street, TradingView, Morningstar, Penny Stock Hub, Stockwatch, OTC Markets, Investing Online, Otc.Watch, Investors Hangout, Stockhouse, 4-Traders, and Global Banking and Finance reported earlier on Medibio Limited (MDBIF), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.
Medibio Limited is a digital health company with offices in Melbourne (Vic), and Minneapolis, Minnesota. It has developed an objective testing system to assist in the screening, diagnosis, and treatment effectiveness of depression, chronic stress, and other mental health disorders. The test uses patented (and patent pending) circadian heart rate variability and cloud based proprietary algorithms to deliver a quantifiable measure to assist in clinical diagnosis. Medibio lists on the OTC Markets’ OTCQB.
Medibio is on course to commercialize its platform technology called the Digital Mental Health Platform. The basis of this is on patented biomarkers from the autonomic nervous system. The Company’s technology will provide a Diagnosis Aid to help General Practioners (GPs) and mental health clinicians. Medibio’s technology provides the first objective measure of stress. It provides a series of user and corporate dashboards for assessment and wellness partner interventions.
Regarding biomarker based objective diagnosis, a panel of circadian, sleep, and automatic system biomarkers enables automated, repeatable, and objective characterization of the impact of mental illness on the physiologic state. Medibio’s Digital Mental Health Platform is a device agnostic platform. It can ingest data from many devices. It is highly scalable, low cost, as well as easy to integrate.
Medibio announced in October 2018 the release of ilumen™. This is its product and platform for corporate customers. ilumen™ is a corporate wellness product providing employers the ability to offer biometric analysis and objective, data-driven feedback along with a mental wellness assessment to their employees.
Recently, Medibio announced that it signed an exclusive agreement with AIAA to undertake a pilot program for the latest release of its corporate health program, ilumen™. AIAA is one of Australia’s leading life insurers. AIAA is part of the AIA Group, which is the largest independent publicly listed pan-Asian life insurance group. It has a presence in 18 markets around the Asia-Pacific region. AIAA will have access to ilumen™ over a six-month period for its Australia and New Zealand employees.
Medibio Limited (MDBIF), closed Friday's trading session at $0.01788, up 49.00%, on 2,122,573 volume with 132 trades. The average volume for the last 3 months is 39,897 and the stock's 52-week low/high is $0.0013/$0.125.
Bemax, Inc. (BMXC)
Penny Investor Network, StockRockandRoll, PennyStockLocks, Penny Stock Tweets, Stock Guru, Insider Financial, and ResearchOTC reported on Bemax, Inc. (BMXC), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Established in 2012, Bemax, Inc. is a growing global distributor of Disposable Baby Diapers. The Company exports and distributes Disposable Baby Diapers from the United States to developing markets in Africa and Europe. In addition, it exports its private label brands from manufacturers in Asia and distributes to other growing markets. Listed on the OTCQB, Bemax is based in Dallas, Georgia.
The Company’s commitment is to the marketing, distribution, and delivery of high quality disposable baby diapers and wipes to respective target markets. Its current emphasis is to supply its clients with disposable baby diapers from manufacturers in North America where quality is superior.
Bemax is pursuing opportunities in the fast-growing international Consumer Staples and Household Products Industries. The Company focuses on business development and mentoring. It synergizes these models into the household products industry.
Bemax announced in 2017 that it entered into a multi-year private labeling agreement with North American Diaper Company (NADC). With this agreement, Bemax will buy, sell, export, and distribute Mother's Touch disposable diapers in private labeled format and in Bemax packaging not trademarked by NADC. NADC is a foremost U.S. manufacturer of value-priced, eco-friendly disposable baby diapers.
Bemax announced this past April that it filed for trademark with the U.S. Patent & Trademark Office (USPTO) for its brand of Mother's Touch disposable diapers. The Company officially filed for trademark on April 28, 2018 (Serial Number 87899104).
Bemax previously announced that its private label brands of sanitary pads and baby wipes would be available for sales commencing this month. The new Bemax private label brands are available on Walmart.com and on bemaxinc.com/webstore.
Shipment of the Company’s new private label brands to wholesalers and distributors started last month. Furthermore, Bemax will extend sales of its private label to other online selling platforms including target.com to support and grow online sales.
Bemax, Inc. (BMXC), closed Friday's trading session at $0.0002, up 100.00%, on 1,250,000 volume with 1 trade. The average volume for the last 3 months is 674,797 and the stock's 52-week low/high is $0.000099999/$0.0012.
SETO Holdings, Inc. (SETO)
Penny Stock Tweets, OTC Markets, 4-Traders, WalletInvestor, InvestorsHub, and Stockhouse reported on SETO Holdings, Inc. (SETO), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
A development stage company, SETO Holdings, Inc. provides healthcare services. Based in Hanover, Maryland, the Company focuses on three main sectors. These are Health, Education and Clean Energy.
SETO analyzes markets, operations, and guides businesses through the challenges they face. Regarding Healthcare, the Company provides hearing health care and distributes hearing aids via 15 hearing clinics in Maryland and Virginia. Established in 2004, SETO lists on the OTC Markets.
Advanced Hearing Group is the Company’s principal audiology and hearing Services Company. Advanced Hearing Group has clinics across the U.S. Mid-Atlantic region. Seto's Health (SH) division works to expand the Company’s other health services.
Seto Energy (SAE) promotes alternative energy projects in India. In addition, Seto's Education (SE) division promotes health education to the 50-plus active adult community Seto Life (SL).
SETO is working to expand its existing healthcare services within the U.S. The Company is pursuing the implementation of projects in developing markets, particularly in India. Concerning Clean Energy, SETO is expanding its operations to encompass clean energy in developing markets, again specifically in India.
SETO Holdings previously announced that its subsidiary entered the cannabis sector, specifically the $US15 billion medical marijuana sector. This represents a significant expansion within the Company's Health Division.
SETO’s plan is to execute Hydroponic farming techniques for the development of cannabis farming and for the development of products derived from medical marijuana cultivation. Additionally, the Company plans to implement financial technology solutions for the fast expanding, multi-billion-dollar cannabis sector.
Recently, SETO Holdings announced its newest hearing clinic in Frederick, Maryland. This clinic will center on pediatric and geriatric patients. This also boosts Seto Hearing Group's (SHG) presence in the market. SETO has partnered with the Department of Aging as the exclusive hearing care provider for its 20 facilities in Baltimore County, Maryland.
Recently, SETO Holdings announced it will start the development of medical software. This project is being developed under a subsidiary called Setosoft. Setosoft's software applications will augment the Company’s internal efficiencies and that of other healthcare providers. The design phase has been completed. Setosoft is putting together the team of software engineers to implement the project.
SETO Holdings, Inc. (SETO), closed Friday's trading session at $0.03, up 36.3636%, on 20,000 volume with 1 trade. The average volume for the last 3 months is 1,912 and the stock's 52-week low/high is $0.017/$0.065999999.
The Pulse Beverage Corporation (PLSB)
The Green Baron, Greenbackers, Microcap MarketPlace, Wall St Insider Stocks, Ceocast News, SmallCap Network, FreeRealTime, PennyStocksV2, BestStocksDaily, Wall Street Resources, RedChip, Marketbeat.com, HoleinOneStocks.net, and PennyStockClub reported previously on The Pulse Beverage Corporation (PLSB), and today we report on the Company, here at the QualityStocks Daily Newsletter.
The Pulse Beverage Corporation is the maker of Natural Cabana® Lemonades, Limeades, and Coconut Waters. It introduced Natural Cabana® Lemonade in 2012. Since that time, it has developed a multi-national distribution system through more than 155 distributors in 49 U.S. States, Canada, Mexico, Panama, Bermuda, and Ireland. OTCQB-listed, The Pulse Beverage Corporation is headquarterered in Northglenn, Colorado.
The Company’s aim is to be one of the market leaders in the development and marketing of nutritional/functional beverage products, which provide real health benefits to a large portion of the population and are convenient and appealing to consumers.
Pulse Beverage’s business model uses warehouse direct and key accounts. The Company has secured greater than 20,000 listings for its Lemonades and Limeades and over 5,000 listings for its Coconut Waters with regional and national grocery and convenience chain stores.
The Company offers Natural Cabana® Lemonade/Limeade in seven, low-calorie flavors. Additionally, Pulse offers Natural Cabana® Coconut Water in pineapple and natural flavors.
Pulse Beverage teams up with major retailers. These retailers include Walmart, Albertsons/Safeway, Food Max, Kroger, Stater Bros, Houchens, 7-Eleven, United C-stores, Kmart, and Weis Markets. Major retailers also include King Kullen, WinCo Foods, Price Less Markets, Hy-Vee Supermarket, Gristede's Foods, Toot n Totem, and Travel America.
Recently, Pulse Beverage announced that it acquired international distribution for its Natural Cabana® Coconut Waters in the People’s Republic of China (PRC) via its new U.S. based distribution partner, Better4U Food & Beverage, Inc.
Better4U has distribution in the PRC and consumer demand for more than 15,000 cases per month worth a minimum of $450K per quarter in Net Revenues for Pulse. In this partnership, Better4U pays for the product up front. This eliminates the credit risks for Pulse.
Furthermore, in March, Pulse announced that it acquired international distribution for its Natural Cabana® Lemonades & Limeades in the Republic of China (Taiwan) via Better4U Food & Beverage. Better4U has distribution in Taiwan and consumer demand for more than 6,500 cases per month worth a minimum of $200K per quarter in additional Net Revenues for Pulse.
The Pulse Beverage Corporation (PLSB), closed Friday's trading session at $0.0002, up 100.00%, on 260,018 volume with 3 trades. The average volume for the last 3 months is 7,200,453 and the stock's 52-week low/high is $0.000099999/$0.001099999.
Blow & Drive Interlock Corp. (BDIC)
MarketWatch, YCharts, TradingView, Equities.com, and News to Watch reported on Blow & Drive Interlock Corp. (BDIC), and we report on the Company as well, here at the QualityStocks Daily Newsletter.
Blow & Drive Interlock Corp. provides automotive and criminal offender monitoring security products. The Company has its state-of-the-art ignition interlock device, the BDI-747. The device is approved and available in eight states for evidentiary and preliminary screening use. In essence, Blow & Drive Interlock is an offender monitoring and police-grade alcohol detection device manufacturing and offender monitoring business. Blow & Drive Interlock is based in Los Angeles, California.
Interlocks are required for use by DUI or DWI (Driving Under The Influence or Driving While Intoxicated) offenders. This is as part of their mandatory court or motor vehicle department program. The Company’s aim is to have the BDI-747 available to customers across the U.S.
In addition, Blow & Drive Interlock continues to do research and development (R&D) on the next stage of offender monitoring. The Company believes this will be Smartphone enabled monitoring applications, which could reduce or eliminate the requirement for ankle bracelets or hand-held breathalyzers.
The BDI-747 is an ignition interlock device, breath-alcohol testing device about the size of a Smartphone. The ignition interlock device requires the driver to exhale into the device prior to starting the vehicle. The device will prevent the vehicle from starting if the driver's blood-alcohol content exceeds a predetermined set level.
The BDI-747 can record BAC levels. It provides 2-way communication, GPS location technology, and image technology. Moreover, the BDI-747 is wireless.
One of Blow & Drive Interlock’s new products is its Home Alcohol Monitoring Device. This handheld device has a camera and GPS/WIFI & live streaming. It enables those in Judicial and Probation departments to monitor offenders who are required to stay sober from alcohol while on probation.
The Company also has its 4G LTE Live-Streaming Video Body Worn Camera for Law Enforcement. With the 4G LTE Live-Streaming Video Body Worn Camera, Law Enforcement Personnel on the scene can transmit a live feed from their body cameras to headquarters. This allows police decision makers’ access to real time information regarding what each officer is seeing.
The body camera weighs roughly 210g. It provides up to 32 GB of memory and 5-megapixel recording.
Recently, Blow & Drive Interlock introduced BADGECAM. This is a body worn camera akin to the models law enforcement officers use but to protect anyone at anytime. The BADGECAM can be heavily incorporated by Human Resources (HR) departments, security personnel, counter staff, or any other jobs that come with a potential confrontation.
The intention of BADGECAM is to become a vital preventative measure against workplace violence, discrimination, or personal/sexual harassment. With BADGECAM, one can immediately begin recording up to 6 hours of high quality video and audio with a single pull.
The design of BADGECAM is to be affixed to any article of clothing. Blow & Drive Interlock plans to launch the BADGECAM between Q2 and Q3 of 2018.
Blow & Drive Interlock Corp. (BDIC), closed Friday's trading session at $0.0599, up 49.75%, on 500 volume with 1 trade. The average volume for the last 3 months is 3,341 and the stock's 52-week low/high is $0.039999999/$0.137799993.
Yappn Corp. (YPPN)
SmallCapFinancialWire, PennyStocks24, Shiznit Stocks, Stock Shock and Awe, StockRunway, Orbit Stocks, MyBestStockAlerts, Fast Money Alerts, Penny Stock General, TopPennyStockMovers, SmallCapVoice, Information Solutions Group, and Social Hot Dog reported previously on Yappn Corp. (YPPN), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Yappn Corp. is a real-time unique language solutions enterprise that amplifies brand messaging, helps conduct commerce, and provides customer support through globalizing these experiences with its proprietary approach to language. Established in 2010, Yappn provides people and brands the power to be social, conduct commerce, and communicate freely without a language barrier.
Yappn has its headquarters in Markham, Ontario. The Company lists on the OTC Markets’ OTCQB. The Company was previously known as Plesk Corp. It changed its name to Yappn Corp. in March of 2013.
In essence, Yappn approaches the challenge of real-time language translation in a completely innovative manner. The result is enhanced translations based on the context of the content or discussion. Consequently, this substantially improves the translation result. According to Common Sense Advisory, more than 72 percent of consumers say they are more likely to purchase online if the experience is in their preferred language.
Backed by its proprietary technology, Yappn’s advanced algorithms return translation with the correct meaning and context of the message. It does so in real-time. The Company’s system is constructed on an enterprise development methodology. It is hosted on Microsoft’s Azure® cloud-based platform.
Yappn provides products for ecommerce, customer care, enhanced messaging collaboration, and online marketing. Furthermore, the Company provides custom translation solutions to different verticals. These include entertainment, retail, as well as marketing.
Yappn has its e-translation product. This is an advanced product that provides global vendors with the ability to integrate into leading ecommerce marketplace sites.
Yappn offers a complete customizable set of tools to engage consumers in more than 100 languages. Yappn is free for users who want to participate on the Company’s general discussion board, unless otherwise noted.
A user’s language is detected by their browser setting automatically. At the very bottom of the page, a user will find a translator bar with the option to choose many languages. A user selects their language and all Yappn pages immediately translate. Everything a person sees on Yappn is in their language, regardless of the language in which it was initially posted.
In May of 2017, Yappn announced that it was granted a new patent for "Cross-Language Communication Between Proximate Mobile Devices" from the Commissioner of Patents representing the Canadian Patent Office. In addition, the patent was also separately granted in the United States on June 9, 2015 as Patent No. US 9,053,097 B2. Canadian Patent No. 2,835,110 was granted on April 11, 2017. It was received by Yappn on May 3, 2017.
Yappn Corp. (YPPN), closed Friday's trading session at $0.0065, up 85.7143%, on 2,000 volume with 4 trades. The average volume for the last 3 months is 1,487 and the stock's 52-week low/high is $0.0193/$0.049800001.
The QualityStocks Company Corner
- INmune Bio Inc. (NASDAQ: INMB)
- VPR Brands, LP (VPRB)
- Quest Patent Research Corp. (OTCQB: QPRC)
- SinglePoint, Inc. (SING)
- Geyser Brands Inc. (TSX.V: GYSR)
- Neutra Corp. (OTCQB: NTRR)
- Trxade Group Inc. (TRXD)
- Genprex Inc. (NASDAQ: GNPX)
- VIVO Cannabis Inc. (TSX.V: VIVO) (OTC: VVCIF)
- MustGrow Biologics Corp. (CSE: MGRO)
- City View Green Holdings Inc. (CSE: CVGR)
- Spectrum Global Solutions, Inc. (SGSI)
- Sugarmade, Inc. (SGMD)
- Cool Events Inc. (RNWR)
INmune Bio Inc. (NASDAQ: INMB)
INmune Bio (NASDAQ: INMB) co-founder and CEO Dr. RJ Tesi recently reported positive preliminary data from the company’s INB03 Phase I clinical trial in cancer patients during a presentation at Cambridge Healthtech Institute’s 7th Annual Immuno-Oncology Summit in Boston (http://nnw.fm/Wu2Ao). To view the full article, visit: http://nnw.fm/Sd0Ig.
INmune Bio Inc. (NASDAQ: INMB) is a diversified clinical-stage immunology company developing novel therapies that target distinct parts of a patient's innate immune system to fight disease. Drug candidates INKmune™ and INB03 may be used to treat cancer while XPro1595 targets neuroinflammation as a cause of Alzheimer's disease. INmune Bio's product platforms utilize a precision therapy approach to promote the body's innate immune response to treat unsolved problems in medicine.
INmune Bio is the first biotechnology company to close an initial public offering (IPO) in 2019 and commence trading on The Nasdaq Capital Market. The company also received a "Part the Cloud" award from the Alzheimer's Association in 2018 which included a $1 million grant to advance INmune Bio's XPro1595 drug candidate.
INmune Bio's product pipeline targets three segments of concern:
- Alzheimer's disease/dementia claims 5.5 million patients in the United States. INmune Bio views Alzheimer's as an immunologic disease which changes the drug discovery process, changes the way clinical trials are designed, and may provide hope for patients and caregivers.
- Cancer residual disease which is expected to generate more than 1.7 million new cases yearly with an estimated 609,640 fatalities. INMB believe that converting resting Natural Killer ("NK") cells to primed NK cells, which kill cancerous cells on contact, is an important therapeutic strategy to help clear residual disease.
- Resistance to immunotherapy. By preventing the proliferation and function of cells that resist immunotherapy, patients should have a stronger immune response to cancer cells and may respond better to other cancer treatments including immunotherapy and live longer.
INmune Bio Drug Candidates and Clinical Programs
INKmune is a biologic delivery system that primes a patient's resting NK cells to kill cancer. INKmune targets residual disease for patients that have completed initial cancer therapy (surgery, radiation and/or chemotherapy) and have a low burden of disease with a high risk of relapse.
In late 2019, INKmune will start enrolling patients in a phase I/II trial for women with relapsed refractory ovarian cancer. In many patients, cancer relapse after seemingly effective cancer therapy is due to a failure of the patients own NK cells to eliminate minimal residual disease ("MRD").
Using a novel mechanism of action and a precision medicine approach, INKmune therapy should enhance NK cells' ability to eliminate residual disease.
INB03 is a checkpoint inhibitor that targets myeloid derived suppressor cells ("MDSC") which can produce an immunosuppressive shield that prevents a patient's own immune system from attacking the cancer. INmune Bio is currently completing a monotherapy INB03 phase I trial in patients with advanced solid tumors. The INB03 program will transition into a combination therapy clinical program in the summer of 2019 to prepare for a phase II trial in patients resistant to checkpoint inhibitors due to increased MDSC.
Treatment with INB03 should eliminate MDSC in the tumor microenvironment to allow checkpoint inhibitors to be therapeutically effective.
XPro1595 targets the microglial immune cells of the brain that are activated in many Alzheimer's disease patients. These microglial cells are a cause of neuroinflammation that can kill nerve cells and promote synaptic dysfunction – the cause of dementia in Alzheimer's.
The three-month, phase I trial is expected to enroll 18 patients in summer of 2019. It is designed to measure traditional and novel biomarkers of inflammation in patients with mild to moderate Alzheimer's disease who have neuroinflammation. The trial is supported by a $1 million "Part the Cloud" grant from the Alzheimer's Association. Inflammation, especially chronic inflammation, is being recognized as an important part of the pathology of many diseases including cancer and Alzheimer's disease.
Dr. RJ Tesi, M.D., INmune Bio co-founder, CEO and acting chief medical officer, has been a licensed physician since 1982 and a Fellow of the American College of Surgery since 1991. He received his medical degree from Washington University School of Medicine in 1982 and has served many roles in several development-stage biotech companies focused on treatment of neurodegenerative diseases, hematologic malignancies, and other inflammatory diseases.
CFO David J. Moss co-founder, has been with the company since its formation in September 2015. He holds an MBA from Rice University and a bachelor's degree in economics from the University of California, San Diego. Moss has founded, funded and taken public various companies in a variety of industries since 1995.
Mark Lowdell, Ph.D. co-founder, has served as the chief scientific officer and chief manufacturing officer at INmune Bio since the company's formation. He is a professor of cell and tissue therapy at University College London where he has led a translational immunotherapy group since 1994. He has also been a director of cellular therapy at the Royal Free London NHS Foundation Trust. He received his Ph.D. in clinical immunology from London Hospital Medical College, University of London in 1992 and is a qualified immunopathologist.
Christopher J. Barnum is director of neuroscience at INmune Bio. Barnum is a neuroimmunologist with broad expertise across neurodegenerative and psychiatric diseases holding multiple positions in academic and industry. His focus has been on translating inflammatory therapies into clinical treatments for neurologic diseases using a biomarker-directed approach. Barnum's research has been supported by the NIH, the Michael J. Fox Foundation, and the Alzheimer's Association. He received his Ph.D. in neuroscience from Binghamton University.
INmune Bio Inc. (OTC: INMB), closed Friday's trading session at $6.03, up 0.332779%, on 14,139 volume with 117 trades. The average volume for the last 3 months is 33,423 and the stock's 52-week low/high is $5.05999994/$11.50.
- INmune Bio Inc. (NASDAQ: INMB) Advances Clinical Development of INB03
- INmune Bio Reports Second Quarter 2019 Financial Results and Provides Shareholder Update
- INmune Bio Appoints Biotechnology Executive Edgardo Baracchini as New Board Member
VPR Brands, LP (VPRB)
VPR Brands LP (OTCQB: VPRB) was featured today in the 420 with CNW by CannabisNewsWire. Thai state hospitals have stocked up on cannabis oils and are ready to start dispensing them to patients, according to a press release by Anutin Chanvirakul, the Public Health Minister who also doubles as the Deputy Prime Minister of Thailand.
Florida-based VPR Brands, LP (VPRB) is an innovative technology holding company whose assets include patented atomization-related products and technology. VPR Brands' current lineup of products includes accessories and vaporizers for cannabidiol (CBD), cannabis concentrates and extracts. The company is also engaged in product development within the vaping market and partners with top international brands to elevate their products within the vaping industry.
VPR Brands employs a growth strategy centered on high-performance, high-quality products that build exponential brand equity, awareness and loyalty. The company's current product portfolio is comprised of the following:
- GoldLine combines premium ingredients and extracts coupled with the newest in technology to achieve the ultimate selection of cannabidiol (CBD) and hemp-based products available anywhere. The product range is designed for a wide variety of consumers and features edibles such as gummies and pure honey stix, tinctures, pre-rolled flower, vapable products and creams. For more information please visit?www.cbdgoldline.com.
- HoneyStick is a lifestyle brand that combines the features of high tech, high performance, dependability and affordability when it comes to upper tier vaporizers. HoneyStick was first to market in creating a Sub Ohm vaporizer to the latest Ripper and Plasma GQ. The HoneyStick team works with a vast network of growers, extractors and industry figures to bring the needs of patients and recreational users to life. HoneyStick is sold online and through a diverse network of distributors, e-tailers, dispensaries and smoke shops. For more information about HoneyStick, visit?www.vapehoneystick.com.
- Helium brings the vaping experience to a new level with intense flavors that are steeped to perfection and chilled at 20 degrees below room temperature. Helium's chillers are scientifically proven to preserve flavor, freshness and aroma. Helium is in a 50ml durable and squeezable bottle with drip tip that is functional from the start, engineered to deliver 77 percent VG.
- Vaporin delivers Sub Ohm series starter kits. Vaporin also provides an eye-catching display case with multi-packs of selected starter kits, coils and premium e-liquids for retail and dispensary operations.
- Vaporx offers the most current, highest quality products from the best-known brands, including KangerTech, eLeaf, Aspire, Pioneer4You, JoyeTech, Samsung. Vaporx acts as an extension to a client's purchasing department, providing the option to schedule regular product mix refresh for maximum sales.
- GoldLine Hemp products are developed specifically for the convenience store market segment. GoldLine Hemp-only products are created without CBD, providing an alternative product line for consumers who are not ready to experience CBD products but still want to take advantage of this rapidly expanding class of products. GoldLine Hemp-only edible Hemp Gummies debuted at the National Association of Convenience Stores (NACS) Expo in Las Vegas in October 2018 and are now being distributed nationwide. The U.S. convenience store industry, with more than 154, 000 stores nationwide, serves 160 million customers daily and has sales that are 10.8% of the total U.S. retail and food service sales. Visit?www.goldlinehemp.com?for more information about GoldLine Hemp-only products.
- Vapor Store Direct in Fort Lauderdale, Florida, is one of the largest vaporizer and e-liquid wholesalers in the United States. Vapor Store Direct stocks internationally elite brands, vaporizers, tanks/atomizers, coils, e-liquid, e-cigarettes, batteries, glass and accessories.
CEO Kevin Frija is a veteran entrepreneur with nearly 30 years of experience in sourcing, manufacturing, supply chain management, marketing, advertising and brand licensing. In 2009, Frija became the president and chief executive officer of Vapor Corp., one of the first U.S. importers and publicly traded electronic cigarette companies. In 2016, Frija purchased the brands and wholesale business assets from Vapor Corp., which is now owned by VPR Brands. Under his leadership, VPR Brands is pivoting toward cannabis products which is increasing sales and profit margins.
Dan Hoff, chief operating officer, has worked in the vaporizer and e-cigarette industry, serving in various positions at Vapor Corp., including overseeing the financial management, accounting functions, supply chain management, product design and development, and key vendor relations. He has played a pivotal role in building and expanding the cannabis-based products division at VPR Brands, which includes a turnkey OEM vapor solutions program available to farmers, cultivators and extractors. Hoff received his bachelor's degree from the University of Miami School of Business.
VPR Brands, LP (VPRB), closed Friday's trading session at $0.09, up 28.5714%, on 678,815 volume with 67 trades. The average volume for the last 3 months is 113,591 and the stock's 52-week low/high is $0.033799998/$0.119999997.
- 420 with CNW – Thai State Hospitals Start Distributing Marijuana Oils
- VPR Brands LP (VPRB) Building Brand Loyalty via Product Innovation in Cannabis, Nicotine Verticals
- VPR Brands LP (VPRB) Reports Increased Revenues, Narrowed Net Loss During Q1 2019
Quest Patent Research Corp. (OTCQB: QPRC)
Quest Patent Research Corp. (OTCQB: QPRC) is a New York City-based intellectual property (IP) asset management firm operating through majority-owned and controlled operating subsidiaries to deliver financial, strategic and legal resources for IP monetization. Quest currently owns, controls or manages over 115 patents across 11 intellectual property portfolios (http://nnw.fm/F0jpD). The company generates revenues from patent licensing fees of its IP property portfolios and from licensed packaging sales.
Quest Patent Research Corp. (OTCQB: QPRC) is a New York City-based intellectual property (IP) asset management firm operating through majority-owned and controlled operating subsidiaries to deliver financial, strategic and legal resources for IP monetization. Quest currently owns, controls or manages over 115 patents across 11 intellectual property portfolios (https://www.qprc.com/portfolio). The company generates revenues from patent licensing fees of its IP property portfolios and from licensed packaging sales.
Quest creates shareholder value through investment and management interests in intellectual property assets, such as patents, trademarks, copyrights, novel inventions and trade secrets. Through its business, shareholders have the opportunity to participate across a broad portfolio of dynamic assets in the burgeoning intellectual property space.
Invention, protection and commercialization of IP require a deep understanding of dynamic technologies, market fundamentals, competitive landscapes and engagement strategies. Often, IP asset owners/stakeholders lack the requisite resources, experience and/or capacity to access the latent value of their IP assets and opportunities. Quest seeks to bridge this gap, partnering with asset owners – such as inventors, businesses, corporations and law firms – to help them fully realize the value of IP assets through:
- IP Valuation
- Structured Licensing Programs
- Patent Prosecution
- Partial or Full Liquidity
- Portfolio Evaluation
- Portfolio Maintenance
- Legal Advisory
- Attorney/Investor Referral
- Patent Acquisition/Liquidation
At Quest, each partnership is treated as its own entity, with its own focused management comprised of Quest employees and seasoned industry associates. Many of technologies are placed in a wholly owned subsidiary of Quest, benefitting from the broader expertise of the company’s leadership.
Quest’s management team delivers a wealth of experience in strategic business management, intellectual property, finance and marketing. The company’s internal resources, in tandem with its external network of financial, legal and managerial professionals, can develop creative solutions to the myriad of challenges involved in monetizing IP. Quest’s structured diligence and deployment procedures mitigate risks, maximize returns and deliver value to IP owners and shareholders alike.
Quest CEO and President Jon Scahill was the founder and managing director of the Urban-Rigney Group, LLC, a private consultancy specializing in new business/new venture development, operations optimization, and strategic analysis. Prior to launching his consultancy business, Mr. Scahill held numerous positions in sales and marketing, technical management, and product development in the consumer products/flexible packaging arena. Mr. Scahill holds a B.S. in chemical engineering from the University of Rochester, an MBA from Rochester’s Simon Graduate School of Business, and a JD from Pace University Law School. He is a registered patent attorney admitted to practice in New York, Florida, the District of Columbia and before the United States Patent and Trademark Office.
Quest Chief Technology Officer Timothy Scahill recently completed a merger and buyout of Managed Services Team LLC, an IT Managed Services provider. Prior to Managed Services Team, he was president of Layer 8 Group Inc., which merged with Structured Technologies Inc. to form Managed Services Team LLC. In his roles he was responsible for business strategy, acquisition, execution, as well as financial management. Mr. Scahill’s entrepreneurial acumen and proven record of successful management with sole discretionary responsibility, demonstrate the scope of his capability and his value to delivering results. He successfully completed his term on the boards of the Upstate New York Technology Council and Pariemus Rochester. Mr. Scahill completed a six-year term as secretary, executive council and a seat on the board of directors for Habitat for Humanity. He has served as president of the Western New York chapter of The Entrepreneurs Organization and continues to serve on the board as accelerator chair. Mr. Scahill is currently performing Cyber Intelligence, Security and Information Assurance work for an undisclosed organization.
Peter LaFauci is president of CFO Solutions, a Rochester, NY-based consulting firm offering knowledge-based financial and accounting solutions for emerging to medium-size companies. Mr. LaFauci is a seasoned executive with over 25 years of proven success in developing, leading and executing strategy in both publicly and privately held companies within the advertising, software development, internet, manufacturing and emerging technologies sectors. Peter possesses strong research and analytical skills as well as interpreting, summarizing and communicating financial and business information to others. Mr. LaFauci is a graduate of Saint Bonaventure University.
Quest Patent Research Corp. (OTCQB: QPRC), closed Friday's trading session at $0.015, up 30.4348%, on 353,704 volume with 14 trades. The average volume for the last 3 months is 279,963 and the stock's 52-week low/high is $0.0013/$0.039999999.
- Quest Patent Research Corp. (QPRC) is “One to Watch”
- Quest Patent Research Corporation Announces Listing on OTCQB
- Quest Patent Research Corporation to Present at the Planet MicroCap Showcase 2019 on May 1 in Las Vegas, NV
SinglePoint, Inc. (SING)
Technology and investment company SinglePoint (OTCQB: SING) was featured on this week’s episode of MoneyTV with Donald Baillargeon. The internationally syndicated program covers money-focused topics, featuring various companies and in-depth CEO and executive interviews that offer insights into operations and future outlooks. To view the full interview, visit: http://nnw.fm/sv5fF. To view the full press release, visit: http://nnw.fm/R6x7q.
SinglePoint, Inc. (SING) is a diversified holding company with operations in multiple industries and verticals including two high-performing market sectors: legal cannabis and cryptocurrencies. SinglePoint has grown from a full-service mobile technology provider to a recognizable brand with a diverse portfolio of undervalued subsidiaries with multiple revenue streams.
SinglePoint is researching opportunities where it can be an active participant by influencing the strategy and direction of high-potential companies whose verified assets offer attractive possibilities for shareholders. The company is guided by a visionary leadership team with extensive experience in technology, engineering, marketing and raising capital.
SinglePoint is bullish on the cannabis industry, bitcoin and blockchain technologies, which is evident in its recent acquisitions and joint-venture announcements. Recent SinglePoint key highlights include:
- A joint venture with Smart Cannabis Corporation (OTC: SCNA) to license and market Smart Cannabis’ SMART APP. SMART APP enables cannabis growers to measure all aspects of cultivation, from soil nutrient levels to watering cycles and carbon dioxide content in the air. SMART APP will integrate SinglePoint’s bitcoin payment solution to enable growers to process safer and more secure transactions.
- A joint venture with Global Payout (OTC: GOHE) will build on existing financial technology solutions developed by SinglePoint and Global Payout’s subsidiary MoneyTrac Technology, Inc., to fully optimize the delivery of mobile payment applications for domestic and international organizations.
- A joint venture with AppSwarm (OTC: SWRM) to start development on a proprietary delivery application that will enable licensed cannabis delivery services and licensed dispensaries to safely make in-home cannabis deliveries.
- Signed original “Shark Tank” member Kevin Harrington as company spokesman for an innovative, compatible virtual wallet to store any type of cryptocurrency. Harrington recently finished shooting a new national ad campaign featuring SinglePoint and the virtual wallet’s secure method of storing cryptocurrencies.
- Entered into a letter of intent to acquire 100 percent of Bitcoin Beyond, a premier platform that enables merchants to accept bitcoin payments using existing web-enabled point-of-sale devices.
- Through SING subsidiary, SingleSeed, the company will soon offer a proprietary cryptocurrency solution that links both cannabis merchants and consumers who seek to take advantage of bitcoin-powered transactions using debit and credit cards. In addition to making bitcoin-backed card purchases possible, the solution enables cannabis dispensaries to digitally track and manage their product inventories, performing tasks like uploading product data, photos and descriptions. The system deducts items automatically from a dispensary’s product listings when a purchase is made. While this fully KYC-AML compliant point-of-sale platform can be utilized for any other retail setting, it will fill a critical need in the underbanked cannabis industry as it continues to seek non-cash payment solutions outside of traditional banking circles.
SinglePoint CEO and founder Greg Lambrecht leads the company in its mission to capture opportunities through an aggressive expansion strategy across a broad range of assets. Lambrecht oversees all company operations including investor relations, leadership of the board of directors, and daily business activities. As the founder of PCI, a leading consumer product distribution company, Lambrecht negotiated agreements with the nation’s largest retail outlets and led PCI through a NASDAQ listed IPO, raising $10 million.
Eric Lofdahl, SinglePoint’s chief technology officer, has more than 20 years of experience in the technology sector including positions in software development, program management, complex system integration and engineering process definition. Prior to SinglePoint, Lofdahl worked at the Boeing Company where he led a team that successfully developed advanced wireless and satellite data products based on commercial technology for the U.S. Air Force.
SinglePoint President Wil Ralston is well known for his successful track record of building and maintaining great relationships with clients. Ralston graduated cum laude from the WP Carey School of Business at Arizona State University with a degree in Global Agribusiness and a specialization in Professional Golf Management. He is currently recognized by the Professional Golfers Association of America (PGA) as a Class A Professional.
SinglePoint, Inc. (SING), closed Friday's trading session at $0.01314, up 1.0769%, on 774,248 volume with 52 trades. The average volume for the last 3 months is 3,342,089 and the stock's 52-week low/high is $0.009999999/$0.041000001.
- SinglePoint, Inc. (SING) President Discusses CBD Cigarette Product on MoneyTV with Donald Baillargeon
- SinglePoint Inc. (SING) CEO Discusses Solar Business, CBD Developments in Interview on the RedChip Money Report
- SinglePoint Interview to Air on Bloomberg International on the RedChip Money Report
Geyser Brands Inc. (TSX.V: GYSR)
Geyser Brands Inc. (TSX.V: GYSR) was featured today in a report by NetworkNewsWire, detailing how, as cannabis edibles and beverages are becoming more popular, the nanoemulsions market is experiencing rapid growth. Nanoemulsion-infused cannabis beverages offer a solution to some of the most common problems that the sector is facing, including the limited efficacy of hemp-derived products caused by the insoluble nature of the molecules. Also today, NetworkNewsWire released a separate report on the company looking at how GYSR’s wholly owned subsidiary, Apothecary Botanicals, has received a standard processing license from Health Canada. To view the full article, visit: http://nnw.fm/DsR0J
Geyser Brands Inc. (TSX.V: GYSR) is a consumer healthcare company that builds and markets some of the world's most loved cannabis products and brands in the nutraceutical, cosmetics, food and beverage and pet sectors. Using its proprietary nanotechnology formulation, the company delivers creams, beverages, baked goods and tincture formulations with superior bioavailability and water solubility.
The efficacy of most hemp?products is restricted as the insoluble nature of the molecules prevents most of the product from permeating the skin or entering the body system. Geyser Brands solves this insolubility problem with an advanced delivery system that quickly and efficiently transports therapeutic agents directly to the bloodstream for maximum absorbency.
Made with all-natural materials, NanoFusion technology offers an array of advantages: enhances penetration for deeper skin penetration; improves the transport of active ingredients for site-specific targeting; delivers active ingredients across cell membranes for release within the cell; provides longer shelf-life and stability of molecules.
Geyser Brands operates a 7,000-square-foot facility in Port Coquitlam, British Columbia, where its initial cannabis cultivation generated the first revenues out of the company's cultivation license granted in October 2018. Geyser Brands is approved as a licensed producer in compliance with Health Canada standards, which allows the company to pursue its processing and sales license. Obtaining this license will enable the company to extend its products and brands into the regulated Canadian cannabis market and directly to the consumer medical market.
Geyser Brands's integrated production chain and formulation lab develops innovative products using high-quality hemp and CBD for healthy lifestyle brands while its R&D lab produces product formulations designed to enhance bio-availability of hemp and CBD and shelf stability while maintaining all-natural ingredients and ensuring premium quality.
Geyser Brands will continue to seek opportunities to invest into the research and development of unique high-quality proprietary strains and technologies that target specific health-related conditions such as pain and inflammation reduction, insomnia, digestive issues and other commonly known ailments.
Among the brand formulations in Geyser Brand's portfolio are:
- Apothecary all-natural Hemp Terpene Pain Cream with optimal skin permeation
- Prohibition Cold Brew Mocha designed with water soluble hemp molecules
- Apothecary health products created to deliver fast-acting and high bioavailability in a spray formulation
- Baked hemp infused pet products, designed to alleviate anxiety and pain, created with NanoFusion for dosage control
Since 2014, Geyser Brands' CEO and Co-Founder Andreas Thatcher has been a principal at Rhizome Group, an entertainment company focused on building media IP through creative and market development. He previously was a founding partner at Rhizome Capital LLC, a U.S.-based media?investment?company specializing in marketing and distribution financing, and worked in the Investment Banking industry in?London and Toronto. Thatcher holds a master's degree in economics.
CFO Barry McKnight obtained his bachelor's degree from the University of British Columbia and is a Chartered Professional Accountant and?Certified Management Accountant registered in British Columbia. McKnight has over 20 years of experience as the principal of Barry D. McKnight Inc. He formerly was also a director of Indigo Sky Capital Corp. and has been the CFO and a director of the Company since 2016 and Corporate?Secretary of the Company since 2017.
Geyser Brands's Co-Founder Brad Kersch brings a strong business background with over 20 years of experience in?successful startups and working?with Fortune 500 companies. He spent his early years in the advertising and?marketing field and went on to form Hyperware, a clothing?company that sold branded clothing to retailers across Canada?before selling to clothing giant Ocean Pacific (OP). Kersch?became the president of Shoreline Studios, Canada's largest and?oldest?studio for film and TV. In 2014 he started Solace Management Group, a hemp product company focused on pet, cosmeceutical, and nutraceutical markets. As of February 2019, Geyser Brands signed a non-binding LOI to acquire Solace Management. Upon completing the proposed Solace acquisition, Geyser Brands intends to launch into the execution phase of its plan — to take its brands global through retail and digital direct-to-consumer experiences, launching its hemp-infused cannabis brands and products in the U.S., European Union, and Asia, and its CBD-infused line of products in jurisdictions where the therapeutic ingredient is legal.
Kuldip Gill, head of Geyser Brands' R&D program, has more than 35 years of experience in the cannabis industry. Gill built the largest manufacturing facility?in the lower mainland in Surrey, British Columbia, complete with R&D, analytical and quality control labs approved by both the FDA and Health Canada. He has to date created over 3,500 formulas, most notably Lakota pain relief gel. Gill's experience and proven track record is evident in the strongly marketable formulations he has developed and sold worldwide.
Geyser Brands Inc. (TSX.V: GYSR), closed Friday's trading session at $0.45, even for the day, on 280 volume. The average volume for the last 3 months is 3,984 and the stock's 52-week low/high is $0.449999988/$0.850000023.
- The Future of Cannabis Edibles is Nanoemulsions, Geyser Brands Inc. (TSX.V: GYSR) Offering Advanced Delivery System
- Geyser Brands Inc. (TSX.V: GYSR) Subsidiary Attains License, Enables Health Care Brands to Add CBD
- Geyser Brands Inc. (TSX.V: GYSR) Sees Global Opportunities in Growing Portfolio of Health-Focused CBD, Hemp Product Lines
Neutra Corp. (OTCQB: NTRR)
Neutra (OTCQB: NTRR), an early-stage research and development company, is diligently working to establish its position within the increasing hemp-based product and CBD markets. To view the full article, visit: http://nnw.fm/5DHvb.
Neutra Corp. (OTCQB: NTRR) is an early-stage research and development company bringing modern healthy living solutions to a multi-billion-dollar market. Cutting-edge technologies within the nutraceuticals, food and drug, and environmental purification sectors are creating a new kind of world culture – one where consumers are demanding access to products that promote health and stave off potential health dangers.
Neutra is concentrating on developing into a vertically integrated company able to cultivate, manufacture and distribute hemp-based cannabidiol (CBD) products. Hemp-based CBD consumer products generated sales of up to $390 million in 2018 with projections pointing to a $3 billion market by 2022, according to the Hemp Business Journal.
Neutra’s new broadened scope, which includes the commercialization of newer, more effective products, aims to capitalize on this worldwide boom. Our company is seeking new and exciting opportunities that can accelerate Neutra’s mission to bring these products to a wider demographic. Our work reflects a renewed dedication to supporting a better body, environment and life for people around the globe.
- Vivis – Neutra is expanding its market presence in the rapidly growing hemp-derived CBD market with a letter of intent to acquire Vivis, an emerging retail brand of hemp-based health and nutritional products. Vivis’ hemp-derived CBD products are third-party certified as contaminant-free and of consistent quality and potency. Consumers are increasingly looking for this certification when they buy hemp-based CBD products. With Vivis as the new retail face of Neutra, the company is expecting greater interest in its expanding portfolio of branded products moving to market.
- J3 Holdings – The signing of a letter of intent to acquire J3 Holdings includes the company’s land and warehouse, as well as a license to cultivate hemp and refine it into usable forms. Neutra has concentrated its early efforts developing business networks and on developing hemp-based CBD products, including supplements and creams. The latest move will enable the company to grow its own hemp supply, giving it more control over the quality of its ingredients.
- Surface to Air Solutions is the North American distributor of a patent-pending, water-based solution known as Purteq, a green technology that works similar to photosynthesis.
- ZeroBlast uses a durable, non-toxic, anti-microbial solution to eliminate all contaminates and kill germs on contact for a period of up to 90 days.
Neutra president and CEO Sydney Jim provides strong executive leadership, a network of business contacts and experience implementing solid corporate strategy. Jim has a proven track record of adding value for public company shareholders. He founded Global Visionary Investments where operational support is provided to seven different companies and their subsidiaries. Jim was also the CEO of First Titan Energy, a microcap public company where he was responsible for restructuring the corporate structure, deal sourcing, and leading the company in mergers and acquisitions.
Dr. Scott Cherry is the company’s sports performance medical advisor. He is an energetic physician executive with a passionate focus on health, performance and prevention. Dr. Cherry received emergency medical technician training in the U.S. Navy, a bachelor’s degree in chemistry from Florida State University, medical degree from Nova Southeastern University, and a master’s degree of public health from Uniformed Services University F. Edward Herbert School of Medicine. Dr. Cherry has honed his skills in a variety of medical and executive positions spanning the U.S. Army and Navy, several Fortune 500 corporations, and major health care facilities over the past 20 years.
Neutra Corp. (OTCQB: NTRR), closed Friday's trading session at $0.0016, even for the day, on 8,540,492 volume with 31 trades. The average volume for the last 3 months is 15,030,769 and the stock's 52-week low/high is $0.0012/$0.14.
- Neutra Corp. (NTRR) Establishing Foothold in Mounting Hemp-Based Product, CBD Markets
- Neutra Corp. (NTRR) Acquisitions Bolster Position in Booming Hemp CBD Sector
- Neutra Corp. (NTRR) is “One to Watch”
Trxade Group Inc. (TRXD)
Trxade Group (OTCQB: TRXD), an integrated pharmaceutical services company, recently announced its financial results for the second quarter of 2019 (http://nnw.fm/j11FM). To view the full article, visit: http://nnw.fm/VR1fN.
Trxade Group Inc. (TRXD) is an integrated pharmaceutical services company that offers a unique combination of a web-based purchasing platform (www.trxade.com) for transactions between independent pharmacists and drug distributors (B2B); a network of pharmacies with E-Hub software; a mail order pharmacy; and warehouse and drug delivery services. This synergistic combination of product offerings and superior data analytics is poised to benefit all stakeholders and consumers within the pharmaceutical industry.
Trxade will leverage and scale its fully integrated model to execute the following growth strategies:
- Increase share of pharmacist drug purchasing
- Additional SKUs and expand product breath
- Partner with Specialty and International Mfg.
- Expand mail order licenses to all 50 states
- Scale Delivmeds for consumer delivery nationwide
- Integration with telemedicine
- M&A Opportunities within drug value chain
Founded in 2010 and headquartered in Tampa, Florida, Trxade's overarching corporate strategy is to penetrate the existing retail independent pharmacy marketplace and diversify the company's pharmaceutical mix with additional specialty and acute care products. Trxade is advancing on this mission by focusing on three key niches in the health care market.
The $330 billion U.S. pharmaceutical industry is comprised of more than 65,000 pharmacy facilities and 1,500 state-licensed suppliers. Roughly 24,000 of these facilities are independent pharmacies, which collectively spend approximately $93 billion a year on branded and generic drugs.
Trxade targets these independent pharmacies, leveraging a robust, "E-Bay/Kayak-like" technology platform with optimum buyer/seller pricing algorithms, product availability, and predictive data analytics features.
Trxade currently serves and transacts with more than one-third (10,250) of these independent pharmacies and facilitates over $10 million of drug purchases a month!
Trxade also targets the "consumer side" of the pharmaceutical industry, aiming to lower prescription drug costs by attacking the inefficient value chain; offering drug price transparency and efficient buying; and, delivering drugs DIRECT to independent pharmacists and consumers.
The company operates a full-service mail order pharmacy for U.S. consumers, as well as a mobile app called "Delivmeds" (http://www.delivmeds.com) which enables SAME DAY home delivery of dispensed prescriptions.
Trxade's Managed Services Organization ("TrxadeMSO") enables its member independent retail pharmacies to get patients, process orders, and deliver or ship prescriptions to patients. TrxadeMSO provides access to encompassing network of pharmacies through the E-Hub software, allowing for timely and comprehensive medication fulfillment.
These offerings ensure the best-suited pharmacy receives the patient's information, thereby ensuring appropriate medication coverage based on the patient's location, payor coverage, and medication access/inventory. This will save the clinicians and their staff time as they benefit from efficiency and enhanced workflow management in script processing and fulfillment.
Health Care Market
The U.S. health care market currently hovers near $4 trillion and is expected to grow as the general population ages. This growth will have greater impact on consumers as out-of-pocket expenses also rise. Additionally, drug costs are paced to increase faster than the overall health care and well above inflation.
Drug pricing is variable, and reimbursement is squeezing profits. This provides significant opportunity for the Trxade model of price visibility and profit optimization.
Trxade's fair online market platform targets the nation's retail community and independent pharmacies, of which there are approximately 24,000 nationwide. TRxADE has found that independent pharmacies, in order to be cost-effective, often operate with minimal staff and conduct up-to-the minute price checks. The TRxADE S2P platform gives these pharmacists the ability to easily compare the price of drugs offered by various suppliers and select the most favorable deals, saving money by taking advantage of best purchase pricing.
TRxADE's programs include:
- TRxADE Exchange, which opens and widens the distribution channel to the retail, community pharmacy. A purchasing pharmacy can view products from manufacturers, buying groups, and wholesalers on a real-time and continuous basis. This approach significantly enhances the competitive spirit of the exchange where the lowest price exists for each product at any given point in time. TRxADE has become a competitive tool for all progressive entities and is recognized for its easy searching of hard-to-find generic pharmaceuticals at substantially reduced prices.
- RX Guru™ is an industry-leading price prediction model that integrates product shortage insight into pharmacy acquisition benchmarks ("PAC") to ascertain trends and pricing variances that result in significant purchasing opportunities. RX Guru affords members the opportunity to continuously benefit from real price purchasing opportunities that are concealed from the rest of the industry.
- Product Shortage Database – TRxADE maintains the most comprehensive retail, specialty and acute care pharmaceutical product shortage database in the country. Other industry competitors mainly restrict their efforts to specialty and acute care product shortages and narrowly research oral generic products. TRxADE's advanced prediction tools help members source those hard-to-find products at affordable costs in a timely and easy-to-search process.
Trxade's management team is rich in expertise within the pharmaceutical supply chain and is supported by a base of advisors and contractors who are experts in related fields of the pharmaceutical sector.
Suren Ajjarapu – Chairman of the Board, Chief Executive Officer and Secretary
Suren Ajjarapu has served as Trxade's chairman of the board, CEO and secretary since 2014, and as the chairman of the board, chief executive officer and secretary of Trxade Nevada since its inception. Ajjarapu also serves as a chairman of the board for Feeder Creek Group Inc., since March 2018. Ajjarapu formerly was a founder, CEO and chairman of Sansur Renewable Energy Inc., a company involved in developing wind power sites in the Midwest, United States; a founder, president and director of Aemetis Inc., a biofuels company (AMTX.OB); a founder, chairman and CEO of International Biofuels, a subsidiary of Aemetis Inc.; and a co-founder, COO, and director at Global Information Technology Inc., an IT outsourcing and systems design company. Ajjarapu holds an M.S. in environmental engineering from South Dakota State University, Brookings, South Dakota, and an MBA from the University of South Florida, specializing in international finance and management. Ajjarapu is also a graduate of the Venture Capital and Private Equity program at Harvard University.
Prashant Patel – Director, President and Chief Operating Officer
Prashant Patel has served as Trxade's full-time president and COO, and as a director since the company's acquisition of Trxade Nevada in 2014, and as the COO and president and as a director of Trxade Nevada since its inception. He has been a president and member of the board of Trxade since August 2010. Patel is a registered pharmacist and pharmaceutical consultant with over 10 years of experience in retail pharmacy and pharmaceutical logistics. He is the founder of several pharmacies in the Tampa Bay area, in Florida. Since 2008, Patel has been managing member of the APAA LLC pharmacy. Since 2007, Patel has been a vice president of Holiday Pharmacy Inc. Patel graduated from Nottingham University School of Pharmacy and practiced in the United Kingdom before obtaining his masters in Transport, Trade and Finance from Cass Business School, City University, UK.
Trxade Group Inc. (TRXD), closed Friday's trading session at $0.95, off by 5.00%, on 1,858 volume with 10 trades. The average volume for the last 3 months is 5,545 and the stock's 52-week low/high is $0.230000004/$1.10000002.
- Trxade Group Inc. (TRXD) Eyes Bright Future Following Encouraging Q2 Financial Results
- Trxade Group Inc. (TRXD) Reports Steady Revenue Growth, Increase in Gross Profits and Independent Pharmacy Subscribers
- Trxade Group Inc. (TRXD) Helps Keep Community Mom and Pop Pharmacies Competitive Amid Health Services Industry Titans
Genprex Inc. (NASDAQ: GNPX)
Genprex Inc. (NASDAQ:GNPX) announces the availability of an audio press release broadcast titled, “Record Revenues, Milestone Achievements Indicate Strength, Potential of Biotech Sector” and produced by NetworkNewsWire (“NNW”). To hear the NetworkNewsAudio version, visit: http://nnw.fm/7MW1l. To read the full editorial, visit: http://nnw.fm/xk1bN
Genprex Inc. (NASDAQ: GNPX) is a clinical-stage gene therapy company developing potentially life-changing technologies for cancer patients based upon a unique proprietary technology platform, including Genprex’s initial product candidate, Oncoprex™ immunogene therapy for non-small cell lung cancer (NSCLC). Genprex’s platform technologies are designed to administer cancer-fighting genes by encapsulating them into nanoscale hollow spheres called nanovesicles, which are then administered intravenously and taken up by tumor cells where they express proteins that are missing or found in low quantities.
Research and Development
Genprex holds a portfolio of 30 issued and two pending patents covering its technologies and targeted molecular therapies. The company’s research and development program is focused on identifying and developing leading-edge gene therapies that can be used alone or in combination with other therapies for treatment of cancer.
Genprex’s initial product candidate is Oncoprex™, an immunogene therapy for the treatment of non-small cell lung cancer (NSCLC). Oncoprex works by interrupting cell signaling pathways that cause replication and proliferation of cancer cells, re-establishes pathways for apoptosis (or programmed cell death) in cancer cells, and modulates the immune response against cancer cells. Oncoprex has also been shown to block mechanisms that create drug resistance.
Preclinical research is being conducted with the goal of developing Oncoprex to be administered with targeted therapies in other solid tumors, and with immunotherapies in NSCLC and other solid tumors. In addition, Genprex has conducted and plans to continue research into other tumor suppressor genes associated with chromosome 3p21.3, as well as other potential applications of the company’s immunogene therapy platform.
Genprex is currently conducting the second phase of a phase I/II clinical trial at the University of Texas MD Anderson Cancer Center in Houston. The company plans to expand its clinical program by adding a new clinical study evaluating Oncoprex™ in combination with a checkpoint inhibitor for treatment of Stage IV or recurrent NSCLC. In research presented at the 2017 Annual Meeting of the American Association of Cancer Research in Washington, D.C., Genprex’s collaborators showed that TUSC2 in combination with PD-1 checkpoint inhibition has a significantly greater anti-tumor effect in lung cancer than either agent alone. The research also shows that TUSC2 in combination with PD-1 blockade has synergistic activity in upregulating natural killer (NK) cells, correlating with prolonged survival in mice.
TUSC2 (Tumor Suppressor Candidate 2) is a tumor suppressor gene that is absent or deficient in cancer cells of many different cancer types.
Genprex technologies seek to bridge a critical gap by combining with targeted therapies and immunotherapies to provide treatments to large patient populations who would otherwise not be candidates for those therapies or who have become resistant to them. Genprex technologies are being developed to overcome genomic limitations which are inherent in targeted therapies and immunotherapies in order to provide new treatment solutions to large cancer populations, such as those with lung cancer.
Each year, more people die of lung cancer than of colon, breast and prostate cancers combined. NSCLC is the most common type of lung cancer, accounting for about 85 percent of all lung cancers, according to the American Cancer Society (“ACS”). Despite radical advances in drug development and novel therapeutic standards, survival for late stage lung cancer has not improved significantly in the past 25 years.
Chairman and Chief Executive Officer J. Rodney Varner, JD, is a co-founder of Genprex and has served in these roles since August 2012. He has more than 35 years of legal experience with large and small law firms and as outside general counsel of a Nasdaq-listed company. Varner has served as counsel in company formation, mergers and acquisitions, capital raising, other business transactions, protection of trade secrets and other intellectual property, real estate, and business litigation. He is a member of the State Bar of Texas and has been admitted to practice before the U.S. Court of Appeals for the Fifth Court and the U.S. Tax Court.
Julien L. Pham, M.D., MPH, is president and chief operating officer of Genprex. In March 2013, Dr. Pham co-founded RubiconMD, a healthcare IT company that connects primary care providers to specialists for additional guidance and opinions on medical cases and served as its chief medical officer. He has served on the faculty at Harvard Medical School’s Brigham and Women’s Hospital and is a board-certified internal medicine doctor and nephrologist.
Ryan M. Confer, MS, has served as Genprex chief financial officer since September 2016. Confer has more than 10 years of executive experience in planning, launching, developing, and growing emerging technology companies and has served in the chief operating and chief financial roles for non-profit and for-profit entities since 2008. Confer has also served as an international business development consultant for the University of Texas at Austin’s IC2 Institute, where he focused on evaluating the commercialization potential of nascent technologies in domestic and international markets applicable to technology incubator programs associated with the University. Confer holds a BS in finance and legal studies from Bloomsburg University of Pennsylvania and an MS in technology commercialization from the McCombs School of Business at the University of Texas at Austin.
Jan Stevens, RN, is vice president of Clinical Operations. Stevens has nearly 20 years of comprehensive clinical operations experience in the biopharma industry and a specialization in early-to-late stage oncology companies. Stevens joined the company to help support the various clinical development programs for Oncoprex™.
Genprex Inc. (NASDAQ: GNPX), closed Friday's trading session at $0.936, off by 2.8743%, on 69,477 volume with 133 trades. The average volume for the last 3 months is 53,886 and the stock's 52-week low/high is $0.640999972/$2.75.
- Genprex (GNPX) Featured in Broadcast Discussing Strength, Potential of Biotech Sector
- Genprex to Present at the RHK Capital 4th Annual Disruptive Growth Conference
- Record Revenues, Milestone Achievements Indicate Strength, Potential of Biotech Sector
VIVO Cannabis Inc. (TSX.V: VIVO) (OTC: VVCIF)
VIVO Cannabis Inc. (TSX.V: VIVO) (OTC: VVCIF) is a globally licensed, cost efficient producer of premium quality, organic, standardized medicinal cannabis. One of the earliest licensed medical marijuana producers under Canada’s federally-controlled Access to Cannabis for Medical Purposes Regulations (ACMPR), VIVO has five years of operating experience in the burgeoning medical marijuana space through its flagship operation, ABcann Medicinals, Inc. The company recently received its Health Canada license to produce medical cannabis oils and is working toward production of saleable, extracted, finished products that will lead to a final inspection allowing sales of its oils.
“Receipt of the license to produce cannabis oils is a major milestone in our pursuit to provide our medical cannabis patients with additional product formats that can be precisely dosed. The expansion and innovation of our product lines are a top priority for the Company as we continue to serve the needs of our customers, and we anticipate strong demand for our cannabis oil products,” VIVO CEO Barry Fishman said.
VIVO owns and operates a fully functioning 14,500 square foot facility in Napanee, Ontario, which is being doubled in size to produce 1,400 kg of cannabis per year. The company’s expansion plans include adding a seasonal greenhouse and a hybrid, multipurpose facility, capable of producing 31,000 kg of cannabis per year between the two facilities, to be constructed on 65 acres it already owns near the Napanee facility. This additional location is properly zoned with existing infrastructure in place for an eventual 1.2 million square feet of production space.
VIVO has built a reputation over the years for its best-in-class standardized approach to growing cannabis that includes the absence of pesticides and a computer monitored growing technique that provides a consistent, pharmaceutical-grade with high yields. The company’s custom, scalable growing chambers with proprietary lighting can be replicated anywhere in the world, leading to lower production costs. This technique has helped it record a customer retention rate of 94.7 percent alongside 30 percent month-over-month customer growth. When combined with VIVO’s current yield rate, which it has measured at roughly 100 percent greater than the industry average, the company has constructed a strong foundation upon which to build a sizable presence in the global cannabis industry.
This global growth potential is illustrated by VIVO’s partnership with Israel’s Syqe Medical, producer of the world’s first selective-dose pharmaceutical grade medicinal plant inhaler. After visiting VIVO’s production facility, Perry Davidson, founder of Syqe Medical, noted that the company’s production technologies put it “in a class with the best in the world” in its ability to produce standardized pharmaceutical grade cannabis.
VIVO’s recent acquisition of Harvest Medicine Inc. represents further progress toward the company’s goal of becoming a vertically integrated medical cannabis company. Harvest Medicine is one of the fastest growing medical cannabis clinics in Canada – adding over 1,200 new patients monthly from a single location – with an aggressive expansion plan and a patient-focused approach that perfectly aligns with VIVO’s philosophy of quality and innovation.
VIVO’s seasoned management team, board of directors and advisory board features well over a century of combined industry experience. Fishman, who has over 20 years of experience as a business leader, previously served as CEO of both Teva Canada and Taro Canada, as vice president of marketing at Eli Lilly Canada, and as past chair of the Canadian Generic Manufacturers Association. He most recently served as CEO of international specialty pharmaceutical company Merus Labs.
Notably, VIVO also has access to the ‘Father of Cannabis Research’, Raphael Mechoulam, PhD, through its board of advisors. An organic chemist and professor of medicinal chemistry at the Hebrew University of Jerusalem, Mechoulam was the first scientist to isolate both cannabidiol (CBD) and tetrahydrocannabinol (THC). He has received more than 25 prestigious academic awards, including the Rothschild Prize in Chemical Sciences and Physical Sciences in 2012.
With more than 65 acres of growth capacity, a healthy cash balance to fund upcoming construction efforts, steady sales growth, industry-leading yield rates and an established operations team in place, VIVO is well positioned to compete in the rapidly expanding Canadian cannabis industry and beyond.
VIVO Cannabis Inc. (VVCIF), closed Friday's trading session at $0.33248, off by 0.781856%, on 215,111 volume with 61 trades. The average volume for the last 3 months is 170,767 and the stock's 52-week low/high is $0.314099997/$1.52999997.
- 420 with CNW – Thai State Hospitals Start Distributing Marijuana Oils
- VIVO Cannabis Inc. (TSX.V: VIVO) (OTCQX: VVCIF) to Release Q2 2019 Financial Results, Host Conference Call VIVO Cannabis to Host Second Quarter 2019 Financial Results Conference Call
MustGrow Biologics Corp. (CSE: MGRO)
The QualityStocks Daily Newsletter would like to spotlight MustGrow Biologics Corp..
Agriculture biotech company MustGrow Biologics Corp. (CSE: MGRO) is dedicated to developing and commercializing non-synthetic Allyl Isothiocyanate (AITC) from mustard seed as a natural fumigant that helps plants defend themselves against pests and harmful fungus activity, thereby providing an alternative to the synthetic pesticides that may harm people while trying to preserve the agricultural products they ingest. MustGrow has specifically focused its development activity on supporting fruit & vegetable, turf & ornamental, tobacco and cannabis products in recent months as it has redirected its output from a granular based product approved by regulators for use in both Canada and the United States to a liquid form that may be particularly beneficial to these industries, as it is delivered through drip lines with increased concentration. Also today, NetworkNewsWire released a report on the company detailing how MustGrow’s IP is well-positioned, as Canada’s licensed producers (‘LPs’) are required by law to demonstrate that no unauthorized pesticides were used on their products or contaminated them (http://nnw.fm/wxHV0). To view the full article, visit: http://nnw.fm/6P7Yf
MustGrow Biologics (CSE: MGRO) is an agricultural biotech company focused on developing and commercializing its patented technology that is a natural biopesticide and biofertilizer for use as a fertilizer, nematicide, pesticide and fungicide. MustGrow’s novel and proprietary solutions utilize organic components refined from mustard seed to provide high quality, organic pest control to growers facing challenges associated with soil-borne diseases and pests such as nematodes. The company’s technology provides an all-natural, effective, safe and easy-to-use solution for farmers seeking to raise healthy crops without the use of pesticides.
Nematodes, or microscopic worms, are the most numerous multicellular animals on earth. A handful of soil will contain thousands of nematodes, many of which are parasites of insects, plants or animals. Most plant-parasitic nematodes feed on the roots of plants, damaging the root system and reducing the plant’s ability to absorb water and nutrients (http://nnw.fm/Qkz21). For the past 50 years, nematodes have been controlled using chemical nematicides, but the Environmental Protection Agency now restricts or bans many of the chemical?formulations.
MustGrow’s technologies provide nematode control that is equal and often superior to synthetic alternatives, resulting in elevated yields and increased returns for the grower. The global economic impact of soil-borne nematodes is estimated at nearly $100 billion in lost crops per year. The American Phytopathological Society (http://nnw.fm/3HGuT), an international nonprofit scientific organization dedicated to the study and control of plant diseases, estimates that plant-pathogenic nematodes are responsible for 14 percent of crop losses worldwide.
MustGrow’s technology refines mustard seeds to concentrate the plant’s natural organic compounds that form Allyl isothiocyanate (“AITC”), which serves the plant as a natural defense system against pests and diseases. As a result, MustGrow’s novel product offers first-class performance, is 100 percent natural, and its fertilizer product is listed for organic use by the Organic Materials Review Institute (“OMRI”) under specifications set by the USDA’s National Organic Program.
MustGrow’s initial technology was a granular pre-plant soil biofumigant and biofertilizer containing the active ingredient AITC, a proven nematicide, fungicide and fertilizer. The company has completed 110 independent third-party field trials on fruit and vegetable crops. As a biofertilizer, MustGrow’s product is registered with Health Canada and the EPA in all U.S. states as OMRI-certified. It is also registered for use as a biopesticide by the EPA in key fruit and vegetable growing U.S. states (except California) and with Health Canada. MustGrow is finalizing a new liquid delivery platform with increased concentration of the same active ingredient (AITC) that can be applied through drip lines to meet the demands of today’s growers.
Results of tests completed to date show that MustGrow continues to provide innovative solutions with broad based applications within agriculture. Validated field trial results include:
- 100 percent control of root-knot nematodes in strawberry crops as compared to methyl bromide
- 55 percent tomato crop yield increase
- 95 percent control of Pythium root rot in lettuce fields
- 70 percent reduction in Verticillium root severity in cucumbers
- Market Opportunity
MustGrow is also testing the potential application of its technology to the cannabis industry, which is projected to grow to nearly $22 billion in the U.S. by 2020. While there are no uniform guidelines for pesticide use in the cannabis industry, state-by-state regulations in the U.S. do exist which has led to instances of pesticide-tainted cannabis showing up in tested products, leading to recalls and threats of lawsuits. Health Canada recently published regulations for mandatory testing for pesticides in cannabis that are now in effect for all growers.?MustGrow’s?potential application for cannabis production shows that when its product is used as a pre-plant/pot soil treatment, it may significantly help control many soil-borne diseases, pathogens and pests, including nematodes, fusarium, rhizoctonia, and botrytis (gray mold) that affect the cannabis plant. Cannabis consumers are increasingly demanding organic products free from chemicals and have shown they are willing to pay a premium for high-quality organic cannabis. MustGrow is currently running cannabis soil trials and is seeking Health Canada approval for use of its product on cannabis.?
Global crop protection is a multibillion-dollar market that is expected to surge over the next five years. Sales of nematicides are set to grow by 33 percent to $1.43 billion by 2022, while biopesticides are projected to leap by 94 percent to an estimated?$9.5 billion by 2022. MustGrow is targeting the global nematicide industry with products that include an innovative pre-plant soil treatment. Solutions for the global biopesticide industry include seed treatment technologies, fungicides and nematicides.??
MustGrow’s groundbreaking technologies use novel plant compounds to provide superior crop protection naturally.
President and CEO Corey Giasson is an entrepreneur with more than 20 years in the agriculture, potash, oil and gas, mining and real estate industries.? Mr. Giasson co-founded Rallyemont Energy Inc., a heavy oil company that successfully identified 140 million barrels of recoverable heavy oil, that was sold in 2013 to Husky Energy. He holds an MBA and bachelor’s degree in agricultural economics from the University of Saskatchewan.
Chairman Brad Munro has 20-plus years as a vice president/investments, with a national venture capital firm where he sourced, invested and managed the activity of over 30 companies and invested $150 million. He has served as a director of over 20 public companies and a greater number of private enterprises. Munro is currently director of Secure Energy Services.
COO Colin Betsky is the previous vice president/BioAg at Novozymes, where he was responsible for the company’s BioAg business worldwide. He holds a bachelor’s degree in agriculture from the University of Saskatchewan and has more than 20 years of experience in agricultural chemicals and biologics.
Director Tom Flow is the founder and current president of The Flowr Corporation (TSX.V: FLWR) and Licensed Producer of cannabis in Canada. He founded and built MedReleaf, Canada’s most profitable Licensed Producer which was later acquired by Aurora Cannabis?(TSX: ACB) (NYSE: ACB) for $3.2 billion. Flow is widely recognized for his leadership and expertise in building and operating cannabis cultivation facilities.
Director Matt Kowalski has a tremendous amount of experience in the fruit and vegetable and biologics industries. Under his leadership at Natural Industries, a business focused on biological pest control, the company was awarded five EPA registrations: three biofungicides, a bionematicide, and a bioinsecticide. In November 2012, Kowalski led the strategic sale of Natural Industries to Novozymes BioAg. He is the principal owner of Stronghold Keep Inc., an investment corporation.
CFO Todd Lahti has extensive experience evaluating and managing start-up companies in the biotechnology, agricultural and oil and gas sectors, working directly on financing transactions, mergers and acquisitions, corporate strategy, business development, technology transfer and operations set up. He is a Chartered Financial Analyst and a Chartered Professional Accountant.
MustGrow Biologics Corp. (CSE: MGRO), closed Friday's trading session at $0.29, off by 6.45%, on 22,000 volume with 5 trades. The average volume for the last 3 months is 60,338 and the stock's 52-week low/high is $0.25/$0.41.
- MustGrow Biologics Corp. (CSE: MGRO) Building Suite of Natural Biologic Products for Cannabis and Other Industries
- MustGrow Biologics Corp. (CSE: MGRO) Developing Natural Biopesticide Products to Ensure Compliant, Pest-Free Cannabis Production
- 420 with CNW – Canadian Startup Makes Headway in Developing Marijuana Breathalyzer for US Police
City View Green Holdings Inc. (CSE: CVGR)
City View Green Holdings (CSE: CVGR) is a vertically integrated cannabis company with a primary focus on the development of a seed-to-retail cannabis network. Recently, the company finalized an agreement securing a 40,000-square-foot cultivation facility that CVGR plans to use to produce a pharmaceutical-grade crop. To view the full article, visit: http://nnw.fm/oZd43.
City View Green Holdings Inc.'s (CSE: CVGR) (formerly Icon Exploration Inc.) primary objective is to create a well-diversified company focused on assessing and potentially acquiring targets in the cannabis industry. Icon Exploration recently signed a formal share exchange agreement relating to its proposed acquisition of privately held City View Green (“CVG”), a vertically integrated cannabis company incorporated under the laws of Ontario, Canada. CVG’s application to Health Canada for an A6ccess to Cannabis for Medical Purposes Regulations (“ACMPR”) license is now at the in-depth review stage of the licensing process.
CVG is preparing a 40,000-square-foot growing facility near Toronto to produce pharmaceutical-grade cannabis once its ACMPR license is granted. About half of the facility will initially be outfitted with state-of-the-art LED lighting, HVAC and dehumidification systems, and automation technologies to optimize the quality, safety and consistency of cannabis production. About 4,000 square feet will be devoted to an extraction laboratory featuring an ultra-efficient CO2 supercritical extraction process with plans to include ethanol extraction technology in the future.
Another 4.3 acres remains available for future construction of up to 125,000 square feet of grow and extraction space. Production plans include producing high quality edible products, distillates, and water-soluble products for the rapidly expanding CBD-infused (cannabidiol) beverage market.
Icon and CVG have assembled a talented team that includes a Master Grower with cannabis-industry experience to manage indoor grow operations and an extraction expert whose expertise in developing and launching new products was honed while working in Washington state’s cannabis sector. Having gained experience in the Washington state market the extraction expert has a number of brand ideas and recreational cannabis products that became popular in the Washington market as well as a number of in-licensing branding opportunities available to CVG. CVG has also negotiated an agreement with a private company seeking 37 retail cannabis licenses in Alberta, Canada, that provides a reciprocal exchange of shares, product, shelf space and distribution lines. Early discussions with various entities in Europe to arrange an off-take agreement for CBD oils and extracts are also underway.
The Canadian medical cannabis market has steadily been growing with an average 10 percent increase in patients each month. Now that the Canadian federal government has legalized recreational cannabis for adult users nationwide, analysts project a compound annual growth rate of nearly 78 percent from 2018 to 2021, reaching an estimated $3 billion by 2021, ArcView Market Research reports. One study from Deloitte pegged the potential economic impact of legalized medical and recreational marijuana in Canada – including transportation, licensing fees and security – at more than $22 billion over the coming years. Health Canada’s most recent data show that sales of cannabis extracts grew 961 percent in the second quarter of 2017, compared to an 89 percent increase in growth of dried cannabis during the same period.
City View Green Holdings Inc. (CSE: CVGR), closed Friday's trading session at $0.13, off by 3.70%, on 30,000 volume with 3 trades. The average volume for the last 3 months is 105,475 and the stock's 52-week low/high is $0.094999998/$0.5125..
- City View Green Holdings Inc. (CSE: CVGR) Creating Seed-to-Retail Cannabis Network
- City View Green Holdings Inc. (CSE: CVGR) Anticipates ‘Greatly Improved’ Timelines for Inspection, Approvals at Brantford Facility
- City View Green Holdings Inc. Unaware of Any Material Change
Spectrum Global Solutions, Inc. (SGSI)
Spectrum Global Solutions Inc. (OTCQB: SGSI) recently announced that it received $3.7 million in new contracts during the second quarter of 2019 in a press release detailing the company’s financial results for the three-month period (http://nnw.fm/LCk8G).
Spectrum Global Solutions, Inc. (SGSI) is a leading single-source provider of end-to-end, next-generation wireless and wireline network infrastructure services and staffing solutions to the service provider (carrier) and corporate enterprise markets across the United States, Canada, Puerto Rico, Guam and the Caribbean. Spectrum Global Solutions provides services directly to carriers, aggregators, utilities, enterprise, Project Management Organizations (PMO) and Original Equipment Manufacturers (OEM) clientele through the following subsidiaries:
- AW Solutions, Inc. and AW Solutions Puerto Rico, LLC – Provides best-in-class communications infrastructure deployment services to carriers, OEMs, PMOs, utilities and enterprise clients by offering discrete and full turnkey service solutions for wireless and wireline clientele. AW Solutions holds professional engineering licenses in all contiguous states and in the District of Columbia and Hawaii; the Canadian provinces of British Columbia, Quebec, Ontario, Alberta and Newfoundland and Labrador; in Puerto Rico, Guam and the U.S. Virgin Islands.
- ADEX Corporation and ADEX Puerto Rico, LLC – An international service organization providing turnkey services and staffing solutions to telecommunications carriers and enterprise clients. Since 1993, ADEX has been assisting telecommunications companies throughout the project life cycle of any network deployment. ADEX and its service capabilities extend from the most basic installation functions to the most advanced engineering disciplines for today and tomorrow’s communications networks. Headquartered in Atlanta, Georgia, ADEX employs technical professionals and provides infrastructure services worldwide via domestic and international locations.
- Tropical Communications, Inc. – A state licensed electrical and underground utility contractor headquartered in Miami, Florida, providing all types of communications and infrastructure facility structured wiring services and solutions since 1984.
Through its subsidiaries, Spectrum Global Solutions is a comprehensive single-source provider for professional services and solutions for the development, deployment and maintenance of wireless/Distributed Antenna System (DAS)/small cell/wireline and fiber networks and infrastructure. The company’s services range in scope from a single activity to multiyear, multi-region, large-scale turnkey development contracts with a deepening pool of international, national, regional and local projects. Spectrum Global Solutions has completed more than 150,000 project activities on wireless, DAS, wireline and fiber networks across the United States utilizing licensed professional engineers, project managers, technicians and general contractors.
Growth projections for the telecom industry show a high growth cycle 2018 through 2025 with a four-fold increase in domestic mobile data traffic and up to $150 billion in fiber investment over the next 5-7 years (Deloitte, 2017). The worldwide explosion of smart phones, tablets and BYOD by customers demanding rapid deployment of new apps, private networks with better coverage and enhanced capacity provides a compelling enterprise opportunity market. The imminent rollout of 5G next generation networks, IOT (Internet-Of-Things) technology deployments, the FirstNet national public safety system, small cell/network densification, Dish Network Deployment, fiber and infrastructure network builds for backhaul and expanded deployments, new FCC spectrum auctions and upgrades to 4G, DAS and small cell networks are contributing to a projected $157 billion in U.S. telecommunication carrier capital expenditures by 2021.
CEO Roger Ponder has served as a director of Spectrum Global Solutions since April 2017. Ponder served as President/CEO of Summit Capital Advisors, LLC, and Summit Broadband, LLC a provider of consulting services to private equity and institutional banking entities in the telecommunications, cable and media/internet sectors. He also served as a member of the board of directors of InterCloud Systems, Inc. and served as its Chief Operating Officer from November 2012 to March 2015. Prior to that Ponder retired from Time Warner Kansas City Division as President/CEO. Ponder brings extensive business development, strategic planning and operational experience to the Company.
Keith Hayter is President of Spectrum Global Solutions and has served as a director of the Company since April 2017. Hayter has also served as the Chief Executive Officer and President of AW Solutions Inc. and AW Solutions Puerto Rico LLC since November 2006. He was Vice President and General Manager of Alcoa Wireless Services from 2001-2006. Hayter served in both the U.S. and British armies and brings extensive multi-national experience in the start-up, development, management and growth of companies in the telecommunication, engineering and construction industry.
Spectrum Global Solutions, Inc. (SGSI), closed Friday's trading session at $0.06, off by 6.25%, on 61,307 volume with 7 trades. The average volume for the last 3 months is 118,162 and the stock's 52-week low/high is $0.032000001/$2.5999999.
- Spectrum Global Solutions Inc. (SGSI) Received $3.7 Million in New Contracts During Q2 2019
- Spectrum Global Solutions, Inc. (SGSI) Receives Over $3.6 Million in New Contract Awards
- Spectrum Global Solutions Inc. (SGSI) Meeting Needs of Flourishing Telecommunications Market
Sugarmade, Inc. (SGMD)
Sugarmade Inc. (OTC:SGMD) today announces its placement in an editorial published by CannabisNewsWire ("CNW"), a multifaceted financial news and publishing company for private and public entities in the cannabis industry. To view the full publication, titled, “Hemp Industry Benefiting From U.S.-Chinese Trade War,” visit: http://cnw.fm/RGn8T.
Sugarmade, Inc. (SGMD), one of the largest publicly traded hydroponics supply companies moving into the industrial hemp space, is a product and brand marketing company investing in products and brands with disruptive potential. Sugarmade’s brands include: ZenHydro.com; CarryOutSupplies.com; and BudLife. Headquartered in Monrovia, California, a city within Los Angeles county, Sugarmade has various business operations in diverse marketplaces including packaging and paper goods for various industries, agricultural supplies.
Sugarmade has expanded into the European hydroponics supply market with a growing base of orders taken through Amazon UK. Over the past few financial quarters, Sugarmade has seen revenue growth patterns expand geographically. As recently as mid-2017, the majority of hydroponic-related revenue growth was seen from California and other West Coast marketplaces, however growth is becoming more geographically dispersed among U.S. states where legalization has eased restriction. This movement into the United Kingdom further expands the base of geographic growth areas for Sugarmade.
Sugarmade recently launched a new corporate initiative in the booming industrial hemp and CBD, committing up to $1 million in capital over the next 12 months to invest in Hempistry, Inc., a privately held Nevada corporation. Hempistry has begun planting an ultra-high cannabidiol (CBD) industrial hemp strain on a land option it holds on 23,000 acres of prime Kentucky farmland. The strain of industrial hemp being grown by Hempistry is ultra-rich in CBD but contains less than 0.3 percent of THC, the psychoactive ingredient found in cannabis. The U.S. hemp industry is expected to produce well over $1 billion in revenues in 2018, with a compound annual growth rate of 14 percent through 2022, according to the Hemp Business Journal.
Demand for industrial hemp and products derived from hemp is soaring, with no let-up in sight, which the company sees as a “tremendous opportunity to become a supplier to this fast-growing sector,” said Chairman and CEO Jimmy Chan, who is also an advisor and minority shareholder of Hempistry.
Sugarmade’s investment into the market for high-CBD hemp is expected to be highly accretive for common shareholders in two ways. First, Sugarmade’s investment will be in the form of common shares in Hempistry allowing Sugarmade common shareholders to possibly benefit from any future initial public offering of Hempistry. Second, Sugarmade is expected to sign a supply agreement with Hempistry for cultivation supplies, which would be additive to corporate revenues.
Sugarmade has also completed a master market agreement with industry leader BizRight Hydroponics, Inc., a leading marketer and manufacturer of cannabis and hydroponic growth supplies, which offers a range of hydroponics-related products including: HPS grow lights, electronic ballasts, HPS bulbs, nutrient mixes, environmental control products, pH measurement and calibration solutions and storage products. BizRight operates the ZenHydro.com website and other e-commerce properties and sells various products to distributors and retailers. BizRight is expected to produce in excess of $30 million in revenues during 2017, with substantial growth expected for 2018.
Sugarmade division CarryOutSupplies.com, the leader in paper and plastic take-out supplies, serves nationwide customers by offering a wide array of high quality products that are cost-efficient, custom-made and delivered on time. This business unit currently serves 2,000 quick service restaurants, garnering from 30-40 percent of the market share. Sugarmade plans to expand operations via the addition of market share and the introduction of new product offerings.
CEO Jimmy Chan is an experienced business executive instrumental in growing multiple business operations with a strong expertise in international trade and banking, and international manufacturing and importation. He is also the founder of CarryOutSupplies.com, a company that revolutionized the custom-printed paper supplies subsector of the quick service restaurant industry, which merged with Sugarmade in 2014.
Arman Tabatabaei serves as operations consultant, providing high-level, day-to-day strategic guidance and tactical operational supervision for all aspects of the corporation’s business. He is an expert at data collection and analysis relative to resource management, risk forecasting and profit and loss management.
Sugarmade specializes in growing and acquiring innovative brands to maximize value for company employees, shareholders and other stakeholders. Sugarmade believes its future is very bright as the company expands operations within the cultivation sector and rapidly increases its revenue base. 6
Sugarmade, Inc. (SGMD), closed Friday's trading session at $0.0153, off by 3.7736%, on 5,011,251 volume with 148 trades. The average volume for the last 3 months is 3,934,931 and the stock's 52-week low/high is $0.00975/$0.197500005.
- Sugarmade Inc. Featured in CannabisNewsWire Publication Discussing Huge Impact of Hemp Industry on Farming
- Hemp Industry Benefiting from U.S.-Chinese Trade War
- Sugarmade Inc. (SGMD) Aims to Capitalize on Kentucky’s Surging Hemp Industry
Cool Events Inc. (RNWR)
Cool Events Inc. (RNWR) offers an array of unique, experiential running and obstacle events that attract thousands of participants sharing a passion for running and helping others. The company produced over 120 events in 2018 under the banner of five successful brands and has already lined up venues for 2019.
Cool Events offers the following trademarked events throughout the nation, with each dedicated to raising funds for important charities: Blacklight Run, the largest glow powder run in the world; Bubble Run, the largest daytime 5K run in the country; Foam Glow, The largest nighttime glow run in the country and the world’s only glowing foam run; Blacklight Slide, the first and only close to five story high Glow-N-Dark water slide with neon glowing water; and Terrain Race, the nation’s fastest growing and industry leading obstacle course race for all ages and athletic abilities.
Cool Events dedicates each of its trademarked runs and events to childhood cancer awareness, making sure this critically important issue is spread throughout the nation one runner, one race at a time. Since its first event in August 2013, the company has donated more than $1 million to Phoenix Children’s Hospital/Children’s Miracle Network and hundreds of thousands more to other charity partners such as Ronald McDonald House Charities of New Mexico, Make-a-Wish Foundation, Adoption Awareness, Special Olympics Massachusetts, St. Jude Children’s Research Hospital, Kendra’s Kisses, Boys and Girls Club and many more over the years.
Cool Events brings a seasoned management team with 35 years of combined experience in operating experiential events including obstacle course races, running races, experiential family events and other competitive events. The Cool Events team also offers consulting, marketing and development for outside events. The company’s in-house marketing agency can handle all brand awareness for event strategy, bringing an event’s vision and goals to life.
Cool Events Inc. (RNWR), closed Friday's trading session at $0.1098, off by 21.5714%, on 148,600 volume with 11 trades. The average volume for the last 3 months is 12,993 and the stock's 52-week low/high is $0.002/$0.231000006.
- Cool Events Inc. (RNWR) Reports Strong Attendance at Signature Fun Runs
- NetworkNewsBreaks – Cool Events Inc. (RNWR) Reports Strong Attendance at Signature Fun Runs
- NetworkNewsBreaks – Why Cool Events Inc. (RNWR) Is 'One to Watch'
The QualityStocks Numbers Report
QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.
The QualityStocks Sponsored News
- Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT) Targets Billion-Dollar AR/VR Market
- Cannabis Strategic Ventures, Inc. (OTCQB: NUGS) Harvests First Cannabis Crop and provides an update on Strategic Investment Partner
- Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) Portfolio Companies Enter Purchase and Supply Agreement, Demonstrate Thriving Ecosystem
- Chemistree Technology Inc. (CSE: CHM) (OTCQB: CHMJF) 420 with CNW – The American Bar Association Asks Congress to Pass Legislation Allowing States to Enact Their Own Cannabis Laws
- ChineseInvestors.com (CIIX) 420 with CNW – The American Bar Association Asks Congress to Pass Legislation Allowing States to Enact Their Own Cannabis Laws
- Choom Holdings Inc. (CSE: CHOO) (OTC: CHOOF) to Acquire 19.9% Equity Interest of Coastal Green, a BC-Based Cannabis Retailer
- City View Green Holdings Inc. (CSE: CVGR) Anticipates ‘Greatly Improved’ Timelines for Inspection, Approvals at Brantford Facility
- Consorteum Holdings, Inc. (CSRH) Universal Mobile Interface Platform Enables Communication Between Different Platforms and Devices
- Cool Events Inc. (RNWR) Reports Strong Attendance at Signature Fun Runs
- Earth Science Tech, Inc. (ETST) Five-Year Plan: Expand Manufacturing, Marketing of Proprietary Products to Diverse Channels
- Endonovo Therapeutics (OTCQB: ENDV) Posts Q2 2019 Financial Results
- Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX) Eye-Net Mobile Successfully Completes Controlled-Environment Trial for the Connected Car Division of a Leading Global Vehicle Manufacturer
- Genprex Inc. (NASDAQ: GNPX) Featured in NetworkNewsWire Publication Discussing Company’s Milestone Achievements
- Geyser Brands Inc. (TSX.V: GYSR) Sees Global Opportunities in Growing Portfolio of Health-Focused CBD, Hemp Product Lines
- Grapefruit Boulevard Investments Inc. (IGNG) Announces Receipt of SEC Comment Letter on its Form S-1 Registration Statement
- Green Growth Brands (CSE: GGB) (OTCQB: GGBXF) Closes C$50.2 Million Bought Deal Financing
- Green Hygienics Holdings Inc. (GRYN) 420 with CNW – Oregon Law Forbids the Sale of Marijuana Byproducts
- Hemptown USA - Advances Growth Strategy via Nutraceutical Manufacturing Facility Acquisition
- INmune Bio, Inc. (NASDAQ: INMB) Reports Second Quarter 2019 Financial Results and Provides Shareholder Update
- IONIC Brands Corp. (CSE: IONC) (OTC: IONKF) Investor Ideas Potcasts, Cannabis News and Stocks on the Move: Interview with Ionic Brands CEO, John Gorst
- Lexaria Bioscience Corp. (CSE: LXX)(OTC: LXRP) Announces Commercial Launch of ChrgD+
- Marijuana Company of America Inc. (MCOA) Announces Launch of New Corporate Website
- MustGrow Biologics Corp (CSE: MGRO) 420 with CNW – Canadian Startup Makes Headway in Developing Marijuana Breathalyzer for US Police
- Nabis Holdings (CSE: NAB) (OTC: NABIF) (FRA: 71P) Enters Alternative Cannabis Consumption Market With 49% Acquisition of Cannova
- Neutra Corp. (OTCQB: NTRR) Acquisitions Bolster Position in Booming Hemp CBD Sector
- Nightfood, Inc. (OTCQB: NGTF) Sports Influencers and Consumer Branding - It's a Win-Win
- Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI) to Commence Trading on the Toronto Stock Exchange on August 22
- ORHub Inc. (ORHB) Settles Litigation with Former Chief Financial Officer
- Pacific Rim Cobalt Corp. (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE) President Issues Letter to Shareholders
- Pacific Software, Inc. (PFSF) Collaborates with Império for Commercial Marketing and Promotion of BOAPIN.com Trade Portal
- Petroteq Energy Inc. (TSX.V: PQE) (OTCQX: PQEFF) is Revolutionizing the Heavy Oil Recovery Process
- Plus Products Inc. (CSE: PLUS) (OTCQB: PLPRF) Expanding Consumer Base through Microdosing Movement
- Pressure BioSciences Inc. (PBIO) Announces Two More Purchase Orders for its Revolutionary BaroShear K45 Processing System for Manufacturing Water-Soluble CBD
- QMC Quantum Minerals Corp. (OTC: QMCQF) (TSX.V: QMC) (FSE: 3LQ) Holds Favorable Position as Rising EV Market Boosts Lithium Demand Worldwide
- Sharing Services Global Corporation (SHRG) Continues to Break Records in the Industry
- SinglePoint, Inc. (SING) CEO Discusses Solar Business, CBD Developments in Interview on the RedChip Money Report
- Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF) Announces Non-Brokered $3M Private Placement with Strategic Investor
- Spectrum Global Solutions, Inc. (SGSI) Receives Over $3.6 Million in New Contract Awards
- Sproutly Canada, Inc. (OTC: SRUTF) (CSE: SPR) (FRA: 38G) 420 with CNW – Colorado Nurses to Launch Cannabis Information Hotline
- Standard Lithium Ltd. (TSX.V: SLL) (FRA: S5L) (OTC: STLHF) Completes Fabrication of Phases 1 & 2 and Begins Mobilisation of Its “LiSTR” Direct Lithium Extraction Demonstration Plant to the Arkansas Project Site
- Sugarmade, Inc. (SGMD) Hemp Industry Benefiting from U.S.-Chinese Trade War
- The Supreme Cannabis Company Inc. (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) Gives Outsized Revenue Guidance, Closes on Truverra Acquisition
- The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Receives 100% Organic Rating from Corporate Knights
- Therma Bright Inc. (TSX.V: THRM) (OTC: THRBF) Continues Testing of TherOZap(TM) Technology Against the Zika Virus
- TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) Appoints Ian Klassen to Board of Directors
- Trxade Group Inc. (TRXD) Reports Steady Revenue Growth, Increase in Gross Profits and Independent Pharmacy Subscribers
- VIVO Cannabis Inc. (TSX.V: VIVO) (OTC: VVCIF) to Release Q2 2019 Financial Results, Host Conference Call
- VPR Brands, LP (VPRB) Building Brand Loyalty via Product Innovation in Cannabis, Nicotine Verticals
- Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) City Cannabis Opens Two New Premier Cannabis Retail Locations in British Columbia
- Willow Biosciences Inc. (CSE: WLLW) 420 with CNW – Why You Should Inform Your Anesthesiologist About Your Cannabis Use
- Youngevity International, Inc. (NASDAQ: YGYI) Reports 2019 Second Quarter and Six Months Results; Q2 Consolidated Revenues Up 21.2%
The QualityStocks DailyNetwork Sponsors
About The QualityStocks Daily
The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.
Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.
"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.